| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 PSG5 CEACAM1 FAT2 HMCN2 PTPRF CNTN2 NRCAM PCDHGC4 DSCAM ESAM CDH24 CELSR2 HMCN1 CDH13 | 6.46e-09 | 187 | 243 | 15 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 PSG5 CEACAM1 FAT2 HMCN2 PTPRF CNTN2 NRCAM PCDHGC4 DSCAM ESAM CDH24 CELSR2 HMCN1 CDH13 | 4.99e-06 | 313 | 243 | 15 | GO:0098742 |
| GeneOntologyBiologicalProcess | neuron projection fasciculation | 1.72e-05 | 28 | 243 | 5 | GO:0106030 | |
| GeneOntologyBiologicalProcess | axonal fasciculation | 1.72e-05 | 28 | 243 | 5 | GO:0007413 | |
| GeneOntologyBiologicalProcess | neuron recognition | 6.72e-05 | 59 | 243 | 6 | GO:0008038 | |
| GeneOntologyCellularComponent | nuclear body | WBP11 HIVEP1 SETX ATRX SRCAP EFTUD2 NFATC1 SCAPER ASCC2 PLAGL1 HEATR5B GCNA CASP8AP2 HDAC5 EP400 USP28 RADX PATL1 BHLHE40 PRX PAPOLG NCOR2 ATF7IP SRRM2 | 1.67e-04 | 903 | 245 | 24 | GO:0016604 |
| GeneOntologyCellularComponent | site of polarized growth | SETX KATNB1 DTNBP1 NRP1 PTPRF PTPRZ1 TSHZ3 HDAC5 DSCAM FRYL EXOC4 | 2.08e-04 | 253 | 245 | 11 | GO:0030427 |
| GeneOntologyCellularComponent | phagophore | 4.07e-04 | 3 | 245 | 2 | GO:0061908 | |
| GeneOntologyCellularComponent | t-UTP complex | 4.07e-04 | 3 | 245 | 2 | GO:0034455 | |
| Domain | Ig-like_fold | GP6 FCRL2 HLA-DOA PSG5 HLA-E NXPE1 CEACAM1 HAVCR1 HMCN2 PTPRF NFATC1 PTPRZ1 ASTN2 MYBPHL SEMA4A MERTK PLXNA1 CNTN2 FN1 NRCAM DSCAM ESAM FSD1 PTPRU HMCN1 TIE1 ATF7IP ROS1 IGSF1 MYBPC2 MYBPC3 | 2.35e-09 | 706 | 240 | 31 | IPR013783 |
| Domain | FN3 | PTPRF PTPRZ1 ASTN2 MYBPHL MERTK CNTN2 FN1 NRCAM DSCAM FSD1 PTPRU TIE1 ATF7IP ROS1 MYBPC2 MYBPC3 | 6.48e-09 | 199 | 240 | 16 | PS50853 |
| Domain | - | GP6 FCRL2 HLA-DOA PSG5 HLA-E NXPE1 CEACAM1 HAVCR1 PTPRF NFATC1 PTPRZ1 ASTN2 MYBPHL MERTK PLXNA1 CNTN2 FN1 NRCAM DSCAM ESAM FSD1 PTPRU HMCN1 TIE1 ATF7IP ROS1 IGSF1 MYBPC2 MYBPC3 | 8.81e-09 | 663 | 240 | 29 | 2.60.40.10 |
| Domain | FN3_dom | PTPRF PTPRZ1 ASTN2 MYBPHL MERTK CNTN2 FN1 NRCAM DSCAM FSD1 PTPRU TIE1 ATF7IP ROS1 MYBPC2 MYBPC3 | 1.31e-08 | 209 | 240 | 16 | IPR003961 |
| Domain | FN3 | PTPRF PTPRZ1 ASTN2 MYBPHL MERTK CNTN2 FN1 NRCAM DSCAM FSD1 PTPRU TIE1 ROS1 MYBPC2 MYBPC3 | 1.74e-08 | 185 | 240 | 15 | SM00060 |
| Domain | fn3 | PTPRF PTPRZ1 MYBPHL MERTK CNTN2 FN1 NRCAM DSCAM FSD1 PTPRU TIE1 ROS1 MYBPC2 MYBPC3 | 2.35e-08 | 162 | 240 | 14 | PF00041 |
| Domain | IGc2 | GP6 FCRL2 PSG5 CEACAM1 HMCN2 PTPRF MYBPHL CNTN2 NRCAM DSCAM ESAM HMCN1 IGSF1 MYBPC2 MYBPC3 | 4.05e-07 | 235 | 240 | 15 | SM00408 |
| Domain | Ig_sub2 | GP6 FCRL2 PSG5 CEACAM1 HMCN2 PTPRF MYBPHL CNTN2 NRCAM DSCAM ESAM HMCN1 IGSF1 MYBPC2 MYBPC3 | 4.05e-07 | 235 | 240 | 15 | IPR003598 |
| Domain | Ig_I-set | FCRL2 CEACAM1 HMCN2 PTPRF MYBPHL MERTK CNTN2 NRCAM DSCAM ESAM HMCN1 MYBPC2 MYBPC3 | 1.12e-06 | 190 | 240 | 13 | IPR013098 |
| Domain | I-set | FCRL2 CEACAM1 HMCN2 PTPRF MYBPHL MERTK CNTN2 NRCAM DSCAM ESAM HMCN1 MYBPC2 MYBPC3 | 1.12e-06 | 190 | 240 | 13 | PF07679 |
| Domain | Ig-like_dom | GP6 FCRL2 HLA-DOA PSG5 HLA-E CEACAM1 HAVCR1 HMCN2 PTPRF MYBPHL MERTK CNTN2 NRCAM DSCAM ESAM PTPRU HMCN1 TIE1 IGSF1 MYBPC2 MYBPC3 | 2.34e-06 | 503 | 240 | 21 | IPR007110 |
| Domain | IG | GP6 FCRL2 PSG5 CEACAM1 HAVCR1 HMCN2 PTPRF MYBPHL MERTK CNTN2 NRCAM DSCAM ESAM PTPRU HMCN1 TIE1 IGSF1 MYBPC2 MYBPC3 | 2.34e-06 | 421 | 240 | 19 | SM00409 |
| Domain | Ig_sub | GP6 FCRL2 PSG5 CEACAM1 HAVCR1 HMCN2 PTPRF MYBPHL MERTK CNTN2 NRCAM DSCAM ESAM PTPRU HMCN1 TIE1 IGSF1 MYBPC2 MYBPC3 | 2.34e-06 | 421 | 240 | 19 | IPR003599 |
| Domain | IG_LIKE | GP6 FCRL2 HLA-DOA PSG5 HLA-E CEACAM1 HAVCR1 HMCN2 PTPRF MYBPHL MERTK CNTN2 NRCAM DSCAM ESAM PTPRU HMCN1 IGSF1 MYBPC2 MYBPC3 | 5.93e-06 | 491 | 240 | 20 | PS50835 |
| Domain | HSA | 8.30e-06 | 4 | 240 | 3 | SM00573 | |
| Domain | HSA | 8.30e-06 | 4 | 240 | 3 | PS51204 | |
| Domain | HSA_dom | 8.30e-06 | 4 | 240 | 3 | IPR014012 | |
| Domain | HSA | 8.30e-06 | 4 | 240 | 3 | PF07529 | |
| Domain | ig | GP6 FCRL2 PSG5 CEACAM1 MERTK CNTN2 NRCAM DSCAM HMCN1 TIE1 IGSF1 | 3.62e-05 | 190 | 240 | 11 | PF00047 |
| Domain | Immunoglobulin | GP6 FCRL2 PSG5 CEACAM1 MERTK CNTN2 NRCAM DSCAM HMCN1 TIE1 IGSF1 | 3.62e-05 | 190 | 240 | 11 | IPR013151 |
| Domain | SNF2_N | 5.10e-05 | 32 | 240 | 5 | IPR000330 | |
| Domain | SNF2_N | 5.10e-05 | 32 | 240 | 5 | PF00176 | |
| Domain | ATG2 | 1.64e-04 | 2 | 240 | 2 | IPR026849 | |
| Domain | ATG2_CAD | 1.64e-04 | 2 | 240 | 2 | PF13329 | |
| Domain | ATG2_CAD_motif | 1.64e-04 | 2 | 240 | 2 | IPR026885 | |
| Domain | AMP-binding | 5.60e-04 | 30 | 240 | 4 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 5.60e-04 | 30 | 240 | 4 | IPR000873 | |
| Domain | PTPc_motif | 9.56e-04 | 59 | 240 | 5 | SM00404 | |
| Domain | Tyr_Pase_cat | 9.56e-04 | 59 | 240 | 5 | IPR003595 | |
| Domain | G2F | 9.70e-04 | 4 | 240 | 2 | PF07474 | |
| Domain | NIDOGEN_G2 | 9.70e-04 | 4 | 240 | 2 | PS50993 | |
| Domain | GFP | 9.70e-04 | 4 | 240 | 2 | IPR009017 | |
| Domain | G2_nidogen/fibulin_G2F | 9.70e-04 | 4 | 240 | 2 | IPR006605 | |
| Domain | MAM_1 | 1.04e-03 | 16 | 240 | 3 | PS00740 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BDP1 DLG5 HIVEP1 SETX ATRX ZGRF1 ZNF318 SRCAP WASHC2A NFATC1 PRRC2C ALDH3A2 DNMBP CASP8AP2 CAD INTS12 HDAC5 EP400 TCOF1 RBM33 USP28 RADX ELP1 E2F2 PAPOLG NCOR2 SETD2 ATF7IP RAB11FIP5 DOT1L CFAP44 ZMYM6 EXOC4 | 5.36e-20 | 588 | 247 | 33 | 38580884 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | STK36 FOXK2 PPRC1 INTS1 MED14 PIGG ATG2A SRCAP ZNF236 WASHC2A RYR1 DIP2A PTPRF NFATC1 FAM83F MTMR3 HERC2 DNMBP GCN1 PLXNA1 WNK2 EP400 RTTN NSD1 CHD8 FRYL ARHGAP35 ORC1 NCOR2 PWWP2B CELSR2 CSPG4 DIP2C NUP188 DOT1L ZNF839 GGA1 ANKRD33B AHNAK2 PPP1R16A | 2.48e-17 | 1105 | 247 | 40 | 35748872 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UBR1 HIVEP1 ATRX JADE3 SEPTIN9 MED14 ZNF318 EFTUD2 SCML2 DNMBP SEC16B EP400 TCOF1 SCAF8 PRPF38B PATL1 ARHGAP35 PAPOLG USP10 NCOR2 SETD2 TAF3 PWWP2B TPX2 SMARCA2 SRRM2 MAP2K2 AKAP1 | 2.22e-12 | 774 | 247 | 28 | 15302935 |
| Pubmed | DLG5 PRSS8 FOXK2 SETX ATRX NACA INTS1 MED14 ZNF318 PIGG SCML2 ASCC2 CRYBG1 PDS5A HERC2 ALDH3A2 HEATR5B DNMBP SLAIN2 CAD INTS12 EP400 RBM33 SCAF8 TOM1 NSD1 NOL11 PRPF38B CHD8 HEATR1 ORC1 USP10 SETD2 PTCD1 TPX2 SMARCA2 CSTF3 AKAP1 | 1.00e-11 | 1497 | 247 | 38 | 31527615 | |
| Pubmed | MED14 ZNF318 SRCAP SCML2 PRRC2C GCN1 SLAIN2 CAD EP400 TCOF1 RANBP3 ATG2B NSD1 CHD8 HEATR1 ARHGAP35 USP10 SETD2 TAF3 SH3D19 TPX2 DOT1L EXOC4 | 1.26e-11 | 549 | 247 | 23 | 38280479 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | STK36 ZNF609 ATG2A DTNBP1 FAM186B ZKSCAN5 PRR14 NFE2L2 PIK3R2 SLA2 WNK2 TSHZ3 HDAC5 EP400 TCOF1 RANBP3 FSD1 PRX NCOR2 TPX2 | 4.59e-11 | 430 | 247 | 20 | 35044719 |
| Pubmed | FCRL2 PSG5 CEACAM1 PTPRF LY6G6D CNTN2 NRCAM DSCAM ESAM PTPRU HMCN1 TIE1 IGSF1 | 1.73e-10 | 162 | 247 | 13 | 25826454 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | WBP11 ZNF609 HIVEP1 SETX SALL3 ATRX SEPTIN9 ZNF318 EFTUD2 SCML2 PRRC2C PDS5A ALK PCBP3 EP400 RBM33 NSD1 NOL11 CHD8 HEATR1 NCOR2 SETD2 TAF3 ATF7IP TPX2 CSTF3 SRRM2 FTSJ3 | 2.79e-10 | 954 | 247 | 28 | 36373674 |
| Pubmed | CDK8 ZNF609 MMP21 ZNF318 SRCAP ZKSCAN5 HMCN2 PIK3R2 SCAPER XYLB SLAIN2 ACTR8 EP400 TCOF1 VEZT SPTLC1 ADNP2 KIAA1549 E2F2 CHD8 NCOR2 SETD2 TAF3 PWWP2B SMARCA2 RAB11FIP5 NUP188 SRRM2 FTSJ3 | 2.12e-09 | 1116 | 247 | 29 | 31753913 | |
| Pubmed | HIVEP1 SETX PIK3R2 HERC2 CPLANE1 GCN1 WNK2 SHANK1 CASP8AP2 RBM33 ADNP2 CHD8 BHLHE40 ATF7IP ARHGEF1 SH3D19 ZNF839 MAP2K2 HERPUD1 | 2.54e-09 | 486 | 247 | 19 | 20936779 | |
| Pubmed | WBP11 ZNF609 FOXK2 HIVEP1 ATRX NACA KLF3 ZNF318 SRCAP WASHC2A PRRC2C PDS5A HERC2 TSHZ3 ACTR8 CAD INTS12 HDAC5 EP400 RBM33 SCAF8 RADX CHD8 PATL1 NCOR2 TAF3 ATF7IP TPX2 SMARCA2 DOT1L SRRM2 EXOC4 FTSJ3 | 2.85e-09 | 1429 | 247 | 33 | 35140242 | |
| Pubmed | STK36 RASSF2 TOGARAM1 ZKSCAN5 EFTUD2 FAT2 SCAPER PDS5A ASTN2 SEC16B ALPK1 ARHGAP35 PRX SETD2 PTCD1 DIP2C SSH2 HERPUD1 EXOC4 | 3.21e-09 | 493 | 247 | 19 | 15368895 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DLG5 HIVEP1 SETX RASSF2 BORCS5 PIK3C3 PRRC2C DNMBP TNS3 SLAIN2 INTS12 HIPK4 RANBP3 FSD1 FRYL ALPK1 ARHGEF1 SH3D19 RAB11FIP5 SSH2 SRRM2 MAP2K2 AKAP1 AHNAK2 EXOC4 | 3.32e-09 | 861 | 247 | 25 | 36931259 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ATRX SEPTIN9 NACA ZNF318 SRCAP EFTUD2 SCML2 PRRC2C ALDH3A2 GCN1 EP400 TCOF1 USP28 RANBP3 ATG2B PRPF38B HEATR1 ARHGAP35 USP10 SETD2 ATF7IP SH3D19 TPX2 AKAP1 AHNAK2 FTSJ3 | 3.77e-09 | 934 | 247 | 26 | 33916271 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | WBP11 ZNF609 SETX SEPTIN9 ZNF280B ZNF318 ZBTB5 PDS5A SLAIN2 EP400 CHD8 BHLHE40 PAPOLG USP10 NCOR2 VWA5A RAB11FIP5 AHNAK2 | 3.85e-09 | 444 | 247 | 18 | 34795231 |
| Pubmed | WBP11 NHSL2 WDR81 ZNF318 EFTUD2 PRRC2C KCNJ4 HERC2 NOS1 WNK2 SHANK1 CAD NRCAM DSCAM TCOF1 USP28 NSD1 GRIA1 CHD8 NBEA USP10 NCOR2 CELSR2 ATF7IP SH3D19 SSH2 | 7.04e-09 | 963 | 247 | 26 | 28671696 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CDK8 BDP1 ZNF609 FOXK2 ATRX SEPTIN9 CDK19 ZNF236 STEAP2 NRP1 NFATC1 PIK3C3 ASTN2 XYLB WNK2 EPB41L4B VEZT SCAF8 TOM1 PRPF38B FRYL PATL1 ARHGAP35 USP10 NCOR2 PWWP2B ZFP64 SMARCA2 DIP2C CSTF3 ZNF839 MAP2K2 EXOC4 | 7.76e-09 | 1489 | 247 | 33 | 28611215 |
| Pubmed | DLG5 ZNF609 FOXK2 NACA WASHC2A SCML2 TNS3 EP400 RBM33 USP28 PRPF38B CHD8 HEATR1 ARHGAP35 SMARCA2 CSTF3 RAB11FIP5 SRRM2 | 9.92e-09 | 472 | 247 | 18 | 38943005 | |
| Pubmed | DLG5 ZNF609 SETX JADE3 NACA ATG2A ZBTB5 DNMBP WNK2 SLAIN2 CASP8AP2 EP400 USP28 KIAA1549 CHD8 USP10 RAB11FIP5 NUP188 IGSF1 | 1.00e-08 | 529 | 247 | 19 | 14621295 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | FOXK2 HIVEP1 SETX ATRX JADE3 INTS1 SRCAP SCML2 PDS5A HERC2 TSHZ3 INTS12 RADX ADNP2 NSD1 CHD8 PAPOLG TAF3 TPX2 DOT1L | 1.75e-08 | 608 | 247 | 20 | 36089195 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ATRX MED14 ZNF318 SRCAP ASCC2 HERC2 CAD EP400 TCOF1 ELP1 CHD8 USP10 SETD2 TPX2 SMARCA2 NUP188 FTSJ3 | 2.13e-08 | 440 | 247 | 17 | 34244565 |
| Pubmed | UBR1 WBP11 ZNF609 SETX ATRX NACA DGKA NRP1 DIP2A PRRC2C PZP RBM47 EPB41L4B SCAF8 ELP1 CHD8 PATL1 ARHGEF1 EXOC4 PLCE1 | 5.22e-08 | 650 | 247 | 20 | 38777146 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZNF609 FOXK2 SETX ATRX JADE3 INTS1 ZNF318 SRCAP EFTUD2 SCML2 NFE2L2 PDS5A CASP8AP2 ACTR8 INTS12 EP400 TCOF1 NSD1 NOL11 HEATR1 BHLHE40 ORC1 NCOR2 SETD2 ZFP64 TPX2 NUP188 SRRM2 FTSJ3 | 5.38e-08 | 1294 | 247 | 29 | 30804502 |
| Pubmed | DLG5 SEPTIN9 ZNF318 ALDH3A2 DNMBP GCN1 EPB41L4B RBM33 RADX KIAA1549 RAB11FIP5 AHNAK2 EXOC4 | 6.08e-08 | 263 | 247 | 13 | 34702444 | |
| Pubmed | CDK8 ZNF609 HIVEP1 MED14 SCML2 INTS12 EP400 RBM33 USP28 RANBP3 CHD8 TPX2 SMARCA2 | 7.57e-08 | 268 | 247 | 13 | 33640491 | |
| Pubmed | CDK8 WBP11 ZNF609 FOXK2 HIVEP1 SETX SEPTIN9 MED14 ZNF318 ACSL1 PRRC2C TOMM34 PDS5A SLAIN2 CAD INTS12 EP400 RBM33 PRPF38B CHD8 CCDC7 NCOR2 TPX2 SMARCA2 CSTF3 SRRM2 | 1.05e-07 | 1103 | 247 | 26 | 34189442 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SETX ATRX SEPTIN9 INTS1 EFTUD2 GCN1 SCAF8 ELP1 CHD8 USP10 NCOR2 ARHGEF1 TPX2 SMARCA2 CSTF3 SRRM2 MAP2K2 EXOC4 | 2.30e-07 | 582 | 247 | 18 | 20467437 |
| Pubmed | INTS1 ZNF318 PRRC2C PDS5A HERC2 GCN1 CAD FN1 TCOF1 NSD1 NOL11 ELP1 CHD8 FRYL HEATR1 SMARCA2 NUP188 SRRM2 FTSJ3 | 2.67e-07 | 653 | 247 | 19 | 22586326 | |
| Pubmed | PRSS8 HIVEP1 ATRX PSG5 ETS2 SEC24D PTPRF ASCC2 PLAGL1 HERC2 MERTK FN1 TOM1 EPG5 NCOR2 ATF7IP CSPG4 GGA1 | 2.87e-07 | 591 | 247 | 18 | 15231748 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | DLG5 NACA ZNF318 PRRC2C GCN1 TCOF1 RANBP3 ATG2B HEATR1 USP10 TPX2 AHNAK2 | 3.49e-07 | 256 | 247 | 12 | 33397691 |
| Pubmed | Uterine inflammatory myofibroblastic tumor: First report of a ROS1 fusion. | 3.54e-07 | 3 | 247 | 3 | 34322931 | |
| Pubmed | CEACAM1 NRP1 FAT2 PTPRF PTPRZ1 MERTK PZP CNTN2 FN1 NRCAM CSPG4 CDH13 | 3.63e-07 | 257 | 247 | 12 | 16335952 | |
| Pubmed | ZNF609 HIVEP1 SALL3 ETS2 KLF3 ZNF280B ZNF318 SRCAP ZNF236 PRR14 NFATC1 NFE2L2 SCAPER ZBTB5 PLXNA1 INTS12 E2F2 BHLHE40 ZSCAN20 ZFP64 SMARCA2 | 3.95e-07 | 808 | 247 | 21 | 20412781 | |
| Pubmed | DLG5 SEPTIN9 NACA PRRC2C DNMBP GCN1 RANBP3 ATG2B PATL1 ARHGAP35 AHNAK2 | 4.77e-07 | 216 | 247 | 11 | 31519766 | |
| Pubmed | DLG5 WBP11 FOXK2 SETX SEPTIN9 NACA NRP1 PRKD3 PRRC2C ASCC2 HERC2 RBM47 GCN1 ALK SEC16B FN1 EP400 TCOF1 NOL11 ELP1 PRPF38B PATL1 USP10 TAF3 TPX2 ROS1 MGME1 FTSJ3 | 6.02e-07 | 1371 | 247 | 28 | 36244648 | |
| Pubmed | 8.27e-07 | 104 | 247 | 8 | 9205841 | ||
| Pubmed | DLG5 WBP11 ATRX WASHC2A EFTUD2 DIP2A PIK3R2 ASCC2 TOMM34 HERC2 ALDH3A2 CASP8AP2 CAD TCOF1 VEZT RANBP3 SPTLC1 KIAA1549 NOL11 ELP1 HEATR1 SLC5A3 USP10 PTCD1 RAB11FIP5 SRRM2 AKAP1 EXOC4 FTSJ3 | 9.47e-07 | 1487 | 247 | 29 | 33957083 | |
| Pubmed | FOXK2 SETX SALL3 ATRX PPRC1 DGKA ZNF318 SRCAP WASHC2A HAVCR1 SCML2 CRYBG1 CPLANE1 FN1 EPB41L4B NSD1 NOL11 FRYL HEATR1 PATL1 PTCD1 ARHGEF1 NUP188 DOT1L | 1.01e-06 | 1084 | 247 | 24 | 11544199 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | FOXK2 INTS1 MED14 SRCAP SCML2 PDS5A EP400 TCOF1 RANBP3 CHD8 TPX2 NUP188 SRRM2 | 1.17e-06 | 341 | 247 | 13 | 32971831 |
| Pubmed | WBP11 ZNF609 NACA WASHC2A SCML2 TOMM34 ITPRIPL1 TNS3 EP400 VEZT RBM33 SCAF8 RADX PATL1 PAPOLG SETD2 TPX2 AKAP1 HERPUD1 | 1.50e-06 | 733 | 247 | 19 | 34672954 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UBR1 SETX SEPTIN9 NACA SRCAP EFTUD2 ACSL1 PDS5A HERC2 GCN1 TNS3 CAD FN1 EP400 ADNP2 NOL11 ELP1 CHD8 HEATR1 ORC1 NCOR2 ARHGEF1 SMARCA2 SRRM2 AHNAK2 EXOC4 FTSJ3 | 1.50e-06 | 1353 | 247 | 27 | 29467282 |
| Pubmed | PPRC1 SEPTIN9 CDK19 WASHC2A RNF157 PRRC2C MTMR3 HDAC5 NRCAM EP400 SCAF8 EPG5 SRRM2 PLCE1 | 1.52e-06 | 407 | 247 | 14 | 12693553 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SETX SEPTIN9 INTS1 PPIL6 DGKA FAM186B RYR1 CHRNB4 DIP2A PDS5A ITPRIPL1 FN1 EPB41L4B PRPF38B NBEA PCIF1 CHRD NUP188 CFAP44 | 1.59e-06 | 736 | 247 | 19 | 29676528 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | ATRX JADE3 MED14 SCML2 HERC2 ACTR8 RBM33 NSD1 CHD8 HEATR1 TAF3 PWWP2B TPX2 SMARCA2 SRRM2 FTSJ3 | 1.61e-06 | 533 | 247 | 16 | 30554943 |
| Pubmed | 1.69e-06 | 13 | 247 | 4 | 33374598 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | FOXK2 JADE3 SEPTIN9 WDR81 ATG2A DTNBP1 WASHC2A SEC24D CRYBG1 HEATR5B TNS3 SLAIN2 HDAC5 TCOF1 RBM33 TOM1 PATL1 ALPK1 SETD2 ARHGEF1 RAB11FIP5 SSH2 MAP2K2 | 1.69e-06 | 1038 | 247 | 23 | 26673895 |
| Pubmed | ZNF609 HIVEP1 ZGRF1 ZNF318 GCN1 CASP8AP2 TSHZ3 HDAC5 ATG2B CHD8 NCOR2 ATF7IP AKAP1 EXOC4 | 2.08e-06 | 418 | 247 | 14 | 34709266 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | SETX DIP2A PRR14 FAM186A MTMR3 HERC2 ALK TNS3 TCOF1 SPTLC1 PTPRU TIE1 CSTF3 SRRM2 | 2.20e-06 | 420 | 247 | 14 | 28065597 |
| Pubmed | STK36 PPRC1 NACA GLYCTK MED14 PTPRF CASP8AP2 CAD EP400 TCOF1 SCAF8 SPTLC1 HEATR1 NCOR2 SETD2 TPX2 ROS1 AKAP1 EXOC4 | 2.26e-06 | 754 | 247 | 19 | 35906200 | |
| Pubmed | Regulation of ETAA1-mediated ATR activation couples DNA replication fidelity and genome stability. | 2.77e-06 | 122 | 247 | 8 | 31615875 | |
| Pubmed | KATNB1 INTS1 MED14 DGKA PIGG EFTUD2 ACSL1 PIK3C3 PRRC2C TOMM34 PARP9 HERC2 HEATR5B GCN1 ITPRIPL1 CAD HEATR1 PAPOLG NCOR2 NUP188 AKAP1 GGA1 HERPUD1 EXOC4 | 3.64e-06 | 1168 | 247 | 24 | 19946888 | |
| Pubmed | WDR81 ATG2A WASHC2A PRKD3 BORCS5 PIK3R2 ALDH3A2 HEATR5B PLXNA1 VEZT TOM1 ATG2B NBEA RAB11FIP5 AKAP1 | 3.80e-06 | 504 | 247 | 15 | 34432599 | |
| Pubmed | WBP11 FOXK2 ATRX INTS1 MED14 TOMM34 PDS5A CASP8AP2 CAD EP400 USP28 NOL11 PRPF38B CHD8 USP10 NCOR2 SETD2 TAF3 TPX2 SMARCA2 CSTF3 MYO15A | 4.01e-06 | 1014 | 247 | 22 | 32416067 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | WBP11 SEPTIN9 NACA INTS1 ZNF318 SRCAP NRP1 EFTUD2 PTPRF HERC2 HEATR5B GCN1 CAD EP400 TCOF1 NOL11 ELP1 HEATR1 CSTF3 NUP188 SRRM2 FTSJ3 | 4.69e-06 | 1024 | 247 | 22 | 24711643 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ZNF609 SEPTIN9 WASHC2A SCML2 PRRC2C ASCC2 DNMBP GCN1 TNS3 PCBP3 EPB41L4B RBM33 NOL11 PATL1 ARHGAP35 USP10 AHNAK2 EXOC4 | 5.05e-06 | 724 | 247 | 18 | 36232890 |
| Pubmed | DCHS2 WBP11 ATRX PPRC1 ETS2 ZKSCAN5 DIP2A NFE2L2 MTMR3 ZBTB5 ASTN2 HERC2 MERTK SHANK1 ACTR8 FN1 NRCAM DSCAM TCOF1 USP28 ADNP2 NBEA BHLHE40 SH3D19 EXOC4 | 5.84e-06 | 1285 | 247 | 25 | 35914814 | |
| Pubmed | WBP11 FOXK2 MED14 SRCAP SCML2 SCAPER TOMM34 EP400 USP10 ZFP64 CSTF3 | 6.12e-06 | 281 | 247 | 11 | 24163370 | |
| Pubmed | ZNF609 FOXK2 INTS1 WASHC2A ZBTB5 GCN1 TSHZ3 EP400 CHD8 SETD2 SMARCA2 | 6.33e-06 | 282 | 247 | 11 | 23667531 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | ZNF609 FOXK2 HIVEP1 ALDH3A2 TSHZ3 EP400 ADNP2 NCOR2 ATF7IP SMARCA2 DOT1L MYO15A MGME1 | 6.33e-06 | 398 | 247 | 13 | 35016035 |
| Pubmed | WBP11 ZNF609 DTNBP1 PTPRF PTPRZ1 MTMR3 HERC2 ALDH3A2 GCN1 TNS3 CAD VEZT KIAA1549 ELP1 NBEA PTPRU NCOR2 CSTF3 RAB11FIP5 SSH2 SRRM2 FTSJ3 | 6.85e-06 | 1049 | 247 | 22 | 27880917 | |
| Pubmed | 9.29e-06 | 103 | 247 | 7 | 10819331 | ||
| Pubmed | CDK8 ZNF609 ATRX INTS1 ZNF236 FAM186B ACSL1 PRDM10 PIK3R2 SCAPER ALDH3A2 GCN1 CAD RANBP3 SPTLC1 PRPF38B CHD8 HEATR1 PATL1 PAPOLG USP10 SETD2 TAF3 NUP188 SSH2 | 1.01e-05 | 1327 | 247 | 25 | 32694731 | |
| Pubmed | WBP11 SRCAP EFTUD2 ALDH3A2 ACTR8 EP400 TCOF1 SCAF8 PRPF38B SRRM2 FTSJ3 | 1.13e-05 | 300 | 247 | 11 | 28561026 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | CDK8 ZGRF1 MED14 WDR81 SRCAP EFTUD2 ZBTB5 TMPPE FN1 EPB41L4B RBM33 RANBP3 | 1.28e-05 | 363 | 247 | 12 | 14691545 |
| Pubmed | SETX ZNF318 EFTUD2 SEC24D TOMM34 PDS5A GCN1 SLAIN2 FN1 EP400 DSCAM TCOF1 EPB41L4B NBEA ATF7IP RAB11FIP5 AKAP1 GGA1 | 1.31e-05 | 777 | 247 | 18 | 35844135 | |
| Pubmed | 1.56e-05 | 202 | 247 | 9 | 24639526 | ||
| Pubmed | 1.93e-05 | 8 | 247 | 3 | 22522930 | ||
| Pubmed | Genome-wide meta-analysis identifies new susceptibility loci for migraine. | 2.02e-05 | 78 | 247 | 6 | 23793025 | |
| Pubmed | CDK8 ZNF609 SETX CDK19 MED14 EP400 USP28 NSD1 BHLHE40 SETD2 TPX2 CSTF3 CDH13 | 2.47e-05 | 453 | 247 | 13 | 29656893 | |
| Pubmed | UBR1 INTS1 SRCAP EFTUD2 GCN1 ACTR8 PCBP3 TCOF1 TAF3 ARHGEF1 MAP2K2 EXOC4 | 2.59e-05 | 390 | 247 | 12 | 17643375 | |
| Pubmed | 2.65e-05 | 329 | 247 | 11 | 17474147 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | SEPTIN9 INTS1 ZNF318 EFTUD2 SCML2 GCN1 EP400 TCOF1 CHD8 FTSJ3 | 2.69e-05 | 271 | 247 | 10 | 32433965 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | ATRX SRCAP EFTUD2 PDS5A GCN1 EP400 CHD8 ATF7IP TPX2 SRRM2 AHNAK2 | 2.88e-05 | 332 | 247 | 11 | 32786267 |
| Pubmed | Substrate specificity analysis and novel substrates of the protein lysine methyltransferase NSD1. | 2.88e-05 | 9 | 247 | 3 | 24412544 | |
| Pubmed | 3.43e-05 | 52 | 247 | 5 | 26633812 | ||
| Pubmed | WBP11 SETX ATRX INTS1 PRRC2C CRYBG1 PDS5A GCN1 HDAC5 EP400 CHD8 TAF3 TPX2 | 3.54e-05 | 469 | 247 | 13 | 27634302 | |
| Pubmed | CDK19 TOGARAM1 GCN1 CASP8AP2 HDAC5 CHD8 ALPK1 ARHGAP35 DIP2C | 3.64e-05 | 225 | 247 | 9 | 12168954 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | CDK8 CDK19 MED14 WDR81 EPB41L4A EFTUD2 HERC2 SLAIN2 HIPK4 EP400 TCOF1 SETD2 FAM222A NUP188 SRRM2 FTSJ3 | 4.29e-05 | 695 | 247 | 16 | 23602568 |
| Pubmed | Autism candidate gene DIP2A regulates spine morphogenesis via acetylation of cortactin. | 4.45e-05 | 28 | 247 | 4 | 31600191 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | ZNF609 FOXK2 HIVEP1 KLF3 TSHZ3 HDAC5 EP400 CHD8 NCOR2 TAF3 SMARCA2 | 4.77e-05 | 351 | 247 | 11 | 38297188 |
| Pubmed | 4.78e-05 | 233 | 247 | 9 | 37704626 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 4.86e-05 | 91 | 247 | 6 | 28558017 | |
| Pubmed | 5.02e-05 | 2 | 247 | 2 | 12386147 | ||
| Pubmed | 5.02e-05 | 2 | 247 | 2 | 28800131 | ||
| Pubmed | 5.02e-05 | 2 | 247 | 2 | 35181333 | ||
| Pubmed | Regulatory functions of the Mediator kinases CDK8 and CDK19. | 5.02e-05 | 2 | 247 | 2 | 30585107 | |
| Pubmed | 5.02e-05 | 2 | 247 | 2 | 24462463 | ||
| Pubmed | 5.02e-05 | 2 | 247 | 2 | 22219374 | ||
| Pubmed | 5.02e-05 | 2 | 247 | 2 | 28368455 | ||
| Pubmed | Recurrent fusion of the genes FN1 and ALK in gastrointestinal leiomyomas. | 5.02e-05 | 2 | 247 | 2 | 27469327 | |
| Pubmed | 5.02e-05 | 2 | 247 | 2 | 31044597 | ||
| Pubmed | 5.02e-05 | 2 | 247 | 2 | 33583243 | ||
| Pubmed | 5.02e-05 | 2 | 247 | 2 | 24858828 | ||
| Pubmed | Immunocytochemical Detection of ALK and ROS1 Rearrangements in Lung Cancer Cytological Samples. | 5.02e-05 | 2 | 247 | 2 | 33683692 | |
| Pubmed | 5.02e-05 | 2 | 247 | 2 | 31392269 | ||
| Pubmed | 5.02e-05 | 2 | 247 | 2 | 22589245 | ||
| Pubmed | Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion. | 5.02e-05 | 2 | 247 | 2 | 30943926 | |
| Pubmed | [Mechanisms of transcriptional regulation upon protein phosphorylation by mediator complexes]. | 5.02e-05 | 2 | 247 | 2 | 20408451 | |
| Pubmed | 5.02e-05 | 2 | 247 | 2 | 10783258 | ||
| Pubmed | 5.02e-05 | 2 | 247 | 2 | 27678455 | ||
| Interaction | TOP3B interactions | STK36 FOXK2 PPRC1 INTS1 MED14 PIGG ATG2A SRCAP ZNF236 WASHC2A RYR1 DIP2A PTPRF NFATC1 FAM83F MTMR3 HERC2 DNMBP RBM47 GCN1 PLXNA1 WNK2 CAD EP400 RBM33 RTTN NSD1 CHD8 FRYL PATL1 ARHGAP35 ORC1 USP10 NCOR2 PWWP2B CELSR2 CSPG4 DIP2C NUP188 DOT1L ZNF839 GGA1 ANKRD33B AHNAK2 EXOC4 PPP1R16A | 2.19e-09 | 1470 | 244 | 46 | int:TOP3B |
| Interaction | TERF2IP interactions | WBP11 ZNF609 FOXK2 HIVEP1 SETX INTS1 ETS2 ZNF318 SRCAP PDS5A EP400 USP28 RADX NSD1 NOL11 CHD8 PRX ORC1 NCOR2 SETD2 ATF7IP TPX2 SRRM2 | 2.85e-07 | 552 | 244 | 23 | int:TERF2IP |
| Interaction | PML interactions | WBP11 ZNF609 SETX ATRX SEPTIN9 ZNF280B ZNF318 ACSL1 PTPRF NFATC1 ZBTB5 PDS5A PLAGL1 PARP9 GCN1 SLAIN2 CASP8AP2 EP400 CHD8 HEATR1 PATL1 ZNF784 BHLHE40 PAPOLG USP10 NCOR2 VWA5A ATF7IP RAB11FIP5 AHNAK2 | 1.10e-06 | 933 | 244 | 30 | int:PML |
| Interaction | HDAC1 interactions | ZNF609 FOXK2 HIVEP1 ATRX ZGRF1 ZNF318 RNF157 EFTUD2 NFATC1 NFE2L2 ASCC2 ZBTB5 PLAGL1 GCN1 PHF21B CASP8AP2 TSHZ3 ACTR8 CAD HDAC5 FN1 EP400 ATG2B CHD8 BHLHE40 NCOR2 PWWP2B ZFP64 SMARCA2 DOT1L AKAP1 EXOC4 FTSJ3 | 1.65e-06 | 1108 | 244 | 33 | int:HDAC1 |
| Interaction | ASF1A interactions | BDP1 FOXK2 HIVEP1 ATRX SRCAP CASP8AP2 EP400 RADX NSD1 CHD8 NCOR2 TPX2 DOT1L ZMYM6 | 2.25e-06 | 249 | 244 | 14 | int:ASF1A |
| Interaction | NUP43 interactions | ZNF609 HIVEP1 SETX JADE3 ZNF318 SRCAP PRRC2C CASP8AP2 PCBP3 EP400 DSCAM NSD1 NOL11 CHD8 HEATR1 NCOR2 SETD2 TAF3 ATF7IP SRRM2 AHNAK2 FTSJ3 | 8.10e-06 | 625 | 244 | 22 | int:NUP43 |
| Interaction | SUPT5H interactions | WBP11 HIVEP1 SETX ATRX INTS1 MED14 WASHC2A EFTUD2 INTS12 FN1 EP400 DSCAM RBM33 RANBP3 NCOR2 DOT1L FTSJ3 | 1.07e-05 | 408 | 244 | 17 | int:SUPT5H |
| Interaction | SNRNP40 interactions | WBP11 ZNF609 HIVEP1 SETX JADE3 ZNF318 EFTUD2 PRDM10 CASP8AP2 EP400 TCOF1 SCAF8 ADNP2 NOL11 HEATR1 PAPOLG NCOR2 SETD2 CSTF3 DOT1L SRRM2 FTSJ3 | 1.09e-05 | 637 | 244 | 22 | int:SNRNP40 |
| Interaction | SIRT6 interactions | FOXK2 ATRX MED14 ZNF318 SRCAP EFTUD2 ASCC2 PDS5A HERC2 CAD EP400 TCOF1 ELP1 CHD8 USP10 SETD2 CELSR2 TPX2 SMARCA2 NUP188 FTSJ3 | 2.80e-05 | 628 | 244 | 21 | int:SIRT6 |
| Interaction | AR interactions | CDK8 ZNF609 HIVEP1 ATRX MED14 ZNF318 SRCAP EFTUD2 SCML2 PIK3R2 PDS5A GCN1 INTS12 FN1 EP400 RBM33 USP28 RANBP3 TOM1 NSD1 CHD8 USP10 NCOR2 TPX2 SMARCA2 CSTF3 NUP188 DOT1L | 2.86e-05 | 992 | 244 | 28 | int:AR |
| Interaction | KDM1A interactions | DLG5 ZNF609 HIVEP1 RASSF2 ZGRF1 KLF3 ZNF318 EFTUD2 NFE2L2 ASCC2 PDS5A GCN1 PHF21B CASP8AP2 CCDC74B TSHZ3 HDAC5 EP400 USP28 ATG2B CHD8 NCOR2 ATF7IP SH3D19 SMARCA2 AKAP1 EXOC4 | 3.02e-05 | 941 | 244 | 27 | int:KDM1A |
| Interaction | PPIA interactions | DLG5 ZNF609 FOXK2 SALL3 NACA WASHC2A FAM186B EFTUD2 SCML2 TNS3 ACTR8 HDAC5 FN1 EP400 EPB41L4B RBM33 USP28 PRPF38B CHD8 HEATR1 ARHGAP35 TAF3 SMARCA2 CSTF3 RAB11FIP5 SRRM2 | 3.05e-05 | 888 | 244 | 26 | int:PPIA |
| Interaction | SMC5 interactions | WBP11 ZNF609 HIVEP1 SETX SALL3 ATRX SEPTIN9 ZNF318 EFTUD2 SCML2 PRRC2C PDS5A ALK PCBP3 EP400 RBM33 NSD1 NOL11 CHD8 HEATR1 NCOR2 SETD2 TAF3 ATF7IP TPX2 CSTF3 SRRM2 FTSJ3 | 3.30e-05 | 1000 | 244 | 28 | int:SMC5 |
| Interaction | SMG7 interactions | ZNF609 HIVEP1 ZNF318 ZBTB5 RBM47 TSHZ3 RBM33 SCAF8 CHD8 PATL1 NCOR2 CSTF3 DOT1L AKAP1 | 3.71e-05 | 319 | 244 | 14 | int:SMG7 |
| Interaction | SMC3 interactions | CDK8 ATRX INTS1 EFTUD2 NFATC1 PDS5A HERC2 MERTK GCN1 CAD HDAC5 PRX SMARCA2 ROS1 DOT1L MAP2K2 | 4.06e-05 | 408 | 244 | 16 | int:SMC3 |
| Interaction | GPR17 interactions | SETX INTS1 PIGG PDS5A HEATR5B TMPPE INTS12 VEZT USP28 HEATR1 SLC5A3 MIGA2 EXOC4 | 4.41e-05 | 283 | 244 | 13 | int:GPR17 |
| Interaction | ETAA1 interactions | 7.01e-05 | 145 | 244 | 9 | int:ETAA1 | |
| Interaction | POLR1G interactions | WBP11 JADE3 SRCAP SPTBN5 PDS5A EP400 TCOF1 NSD1 NOL11 CHD8 HEATR1 TAF3 ATF7IP NUP188 DOT1L SRRM2 FTSJ3 | 1.03e-04 | 489 | 244 | 17 | int:POLR1G |
| Interaction | PROKR1 interactions | 1.07e-04 | 21 | 244 | 4 | int:PROKR1 | |
| Interaction | SUMO2 interactions | SETX ATRX NACA SRCAP EFTUD2 NFE2L2 PDS5A MERTK GCN1 GCNA CASP8AP2 CAD EP400 USP28 CHD8 ATF7IP TPX2 SRRM2 AHNAK2 | 1.14e-04 | 591 | 244 | 19 | int:SUMO2 |
| Interaction | BRD3 interactions | JADE3 ZKSCAN5 SCML2 ACTR8 INTS12 RBM33 NSD1 CHD8 HEATR1 TAF3 PWWP2B TPX2 SMARCA2 RAB11FIP5 DOT1L SRRM2 FTSJ3 | 1.17e-04 | 494 | 244 | 17 | int:BRD3 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr18q23 | 6.42e-05 | 40 | 247 | 4 | chr18q23 | |
| GeneFamily | Fibronectin type III domain containing | PTPRF PTPRZ1 ASTN2 MYBPHL MERTK CNTN2 FN1 NRCAM DSCAM FSD1 PTPRU TIE1 ATF7IP ROS1 MYBPC2 MYBPC3 | 2.52e-12 | 160 | 171 | 16 | 555 |
| GeneFamily | Immunoglobulin like domain containing | GP6 FCRL2 CEACAM1 HMCN2 MERTK CNTN2 NRCAM DSCAM ESAM TIE1 IGSF1 | 2.31e-06 | 193 | 171 | 11 | 594 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | HMCN2 PTPRF MYBPHL MERTK CNTN2 NRCAM DSCAM HMCN1 MYBPC2 MYBPC3 | 3.12e-06 | 161 | 171 | 10 | 593 |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 4.50e-05 | 8 | 171 | 3 | 658 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF609 HIVEP1 SALL3 ZNF862 KLF3 ZNF318 ZNF236 ZKSCAN5 PRDM10 SCAPER ZBTB5 PLAGL1 TSHZ3 ADNP2 ZNF784 ZSCAN20 ZFP64 | 4.74e-04 | 718 | 171 | 17 | 28 |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 5.41e-04 | 40 | 171 | 4 | 321 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 9.75e-04 | 21 | 171 | 3 | 813 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.58e-03 | 53 | 171 | 4 | 532 | |
| GeneFamily | PHD finger proteins | 1.64e-03 | 90 | 171 | 5 | 88 | |
| GeneFamily | Zinc fingers GRF-type|Topoisomerases | 1.81e-03 | 7 | 171 | 2 | 135 | |
| GeneFamily | Fibulins | 2.40e-03 | 8 | 171 | 2 | 556 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 3.06e-03 | 9 | 171 | 2 | 1230 | |
| GeneFamily | Cyclins|Mediator complex | 3.68e-03 | 33 | 171 | 3 | 1061 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 4.01e-03 | 34 | 171 | 3 | 487 | |
| GeneFamily | UPF1 like RNA helicases | 4.62e-03 | 11 | 171 | 2 | 1169 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BDP1 UBR1 ZNF609 SETX ATRX RASSF2 SEPTIN9 HLA-E DGKA PRKD3 DIP2A CRYBG1 PDS5A SLA2 PARP9 SLAIN2 EP400 RBM33 SCAF8 NSD1 ELP1 PRPF38B FRYL ARHGAP35 BHLHE40 EPG5 SLC5A3 PAPOLG SETD2 VWA5A ATF7IP ARHGEF1 SMARCA2 SSH2 | 1.58e-06 | 1492 | 246 | 34 | M40023 |
| Coexpression | AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN | CDK19 PPIL6 NFATC1 PIK3C3 ASCC2 TOM1 ADNP2 E2F2 SMARCA2 SRRM2 GGA1 | 1.62e-05 | 237 | 246 | 11 | M8897 |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_DN | GLYCTK DGKA DTNBP1 SEC24D PTPRF SLA2 SEMA4A TCOF1 BHLHE40 TPX2 | 2.00e-05 | 199 | 246 | 10 | M4549 |
| Coexpression | FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_3DY_POSITIVE | 2.09e-05 | 18 | 246 | 4 | M41040 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CDK8 FOXK2 HIVEP1 SETX ATRX SEPTIN9 CDK19 TOGARAM1 SEC24D PIK3C3 PRRC2C MTMR3 PDS5A DNMBP SCAF8 FRYL ARHGAP35 BHLHE40 NCOR2 SETD2 SMARCA2 PLCE1 | 2.12e-05 | 856 | 246 | 22 | M4500 |
| Coexpression | BILBAN_B_CLL_LPL_UP | 3.06e-05 | 64 | 246 | 6 | M19930 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | DLG5 SETX NACA NFE2L2 ASTN2 HERC2 NOS1 ALK PLXNA1 TNS3 TSHZ3 ACTR8 HDAC5 OLFML2B TOM1 ELP1 NCOR2 ATF7IP TPX2 SMARCA2 COX7A2L SSH2 CDH13 PLCE1 | 3.09e-05 | 1009 | 246 | 24 | M157 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | CDK8 FOXK2 HIVEP1 ATRX SEPTIN9 PIK3C3 PRRC2C PDS5A DNMBP SCAF8 E2F2 FRYL BHLHE40 SETD2 SMARCA2 | 3.84e-05 | 466 | 246 | 15 | M13522 |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN | 5.26e-05 | 139 | 246 | 8 | M8948 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_UP | 6.42e-05 | 184 | 246 | 9 | M9988 | |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | SETX NACA ALK TNS3 TSHZ3 ACTR8 HDAC5 OLFML2B TOM1 ELP1 NCOR2 ATF7IP TPX2 COX7A2L | 8.07e-05 | 441 | 246 | 14 | M172 |
| Coexpression | HAN_SATB1_TARGETS_DN | INHBA KLF3 NRP1 CPT1C ALDH3A2 GCN1 HDAC5 FN1 EP400 RADX ACSF2 BHLHE40 AKAP1 | 8.48e-05 | 388 | 246 | 13 | M15491 |
| Coexpression | GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP | 1.08e-04 | 197 | 246 | 9 | M9569 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_DN | 1.12e-04 | 198 | 246 | 9 | M4554 | |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 1.17e-04 | 199 | 246 | 9 | M7259 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_DN | 1.17e-04 | 199 | 246 | 9 | M8861 | |
| Coexpression | GSE31622_WT_VS_KLF3_KO_BCELL_DN | 1.21e-04 | 200 | 246 | 9 | M8471 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP | 1.21e-04 | 200 | 246 | 9 | M7500 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN | 1.21e-04 | 200 | 246 | 9 | M6583 | |
| Coexpression | GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_UP | RASSF2 TOGARAM1 ZNF318 ATG2A ZBTB5 ARHGAP35 NCOR2 VWA5A MYBPC3 | 1.21e-04 | 200 | 246 | 9 | M6832 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | ZNF609 JADE3 GLYCTK MED14 WDR81 RNF157 PTPRZ1 CPT1C PDS5A ASTN2 PLAGL1 SEMA4A ALDH3A2 WNK2 PHF21B SHANK1 CASP8AP2 GARNL3 NRCAM E2F2 CHD8 FRYL PTPRU ACSF2 ZNF784 KCNRG PAPOLG TPX2 IGSF1 | 4.86e-07 | 893 | 244 | 29 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | ZNF609 ATRX JADE3 GLYCTK MED14 WDR81 ZNF280B DIP2A PDS5A ASTN2 SEMA4A WNK2 PHF21B PIF1 CASP8AP2 GARNL3 NRCAM EPB41L4B PRR30 E2F2 PRPF38B CHD8 FRYL ACSF2 PAPOLG CELSR2 TPX2 IGSF1 | 1.00e-05 | 986 | 244 | 28 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | GLYCTK RNF157 DIP2A PTPRZ1 CPT1C ASTN2 PLAGL1 SEMA4A ALDH3A2 WNK2 PHF21B SHANK1 GARNL3 NRCAM E2F2 NBEA PTPRU ACSF2 ZNF784 KCNRG CELSR2 IGSF1 | 4.10e-05 | 732 | 244 | 22 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | RNF157 DIP2A PTPRZ1 CPT1C ASTN2 PLAGL1 SEMA4A ALDH3A2 WNK2 SHANK1 GARNL3 E2F2 CHD8 PTPRU ACSF2 ZNF784 KCNRG CELSR2 IGSF1 CDH13 ZMYM6 PLCE1 | 5.54e-05 | 747 | 244 | 22 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | RNF157 DIP2A CPT1C ASTN2 PLAGL1 SEMA4A ALDH3A2 WNK2 SHANK1 GARNL3 HDAC5 E2F2 CHD8 NBEA PTPRU ACSF2 ZNF784 KCNRG IGSF1 CDH13 ZMYM6 PLCE1 | 5.54e-05 | 747 | 244 | 22 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#1 | RNF157 DIP2A ASTN2 PLAGL1 SEMA4A WNK2 SHANK1 GARNL3 ACSF2 ZNF784 KCNRG | 8.51e-05 | 233 | 244 | 11 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5 | RNF157 DIP2A CPT1C ASTN2 PLAGL1 SEMA4A ALDH3A2 WNK2 SHANK1 GARNL3 E2F2 CHD8 NBEA PTPRU ACSF2 ZNF784 KCNRG IGSF1 CDH13 ZMYM6 PLCE1 | 9.78e-05 | 722 | 244 | 21 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.11e-04 | 162 | 244 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | RNF157 DIP2A PTPRZ1 CPT1C MTMR3 ASTN2 PLAGL1 SEMA4A ALDH3A2 WNK2 SHANK1 GARNL3 E2F2 CHD8 PTPRU ACSF2 ZNF784 KCNRG IGSF1 ZMYM6 PLCE1 | 1.14e-04 | 730 | 244 | 21 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | EPB41L4A RNF157 DIP2A CPT1C ASTN2 PLAGL1 SEMA4A ALDH3A2 WNK2 SHANK1 GARNL3 NRCAM E2F2 PTPRU ACSF2 ZNF784 KCNRG CELSR2 FAM222A IGSF1 | 1.31e-04 | 683 | 244 | 20 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#2 | GLYCTK RNF157 PTPRZ1 ASTN2 PLAGL1 SEMA4A PHF21B SHANK1 GARNL3 NRCAM CELSR2 | 1.48e-04 | 248 | 244 | 11 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K2 |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-08 | 186 | 247 | 10 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | CEACAM1 NRP1 MERTK PLXNA1 TNS3 KIAA1549 PRX PWWP2B SMARCA2 ANKRD33B | 1.48e-07 | 195 | 247 | 10 | 7e0ef92059ff34e368d2324815f49b50e3ca7332 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.87e-07 | 200 | 247 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.79e-07 | 170 | 247 | 9 | 417b77c12a7982b1ce4b4bc57f30335d261220f5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.82e-07 | 174 | 247 | 9 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.95e-07 | 135 | 247 | 8 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 196 | 247 | 9 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-06 | 197 | 247 | 9 | 49689a03ab31e53386dbe15c77c09ca3a14ebf4e | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.19e-06 | 152 | 247 | 8 | ca23261d8ef263cc697b8d7e7cb2afec8bc564f2 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.20e-06 | 160 | 247 | 8 | 19105debef96ea0c267d6a1d332303ec668ae47e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.36e-06 | 161 | 247 | 8 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-06 | 165 | 247 | 8 | 0edd56e8d14eaeced9882dd9206ea93e8f402e8d | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-06 | 165 | 247 | 8 | fa3aadfff6fb1e7f142db333c60c2cba02b17e6c | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.21e-06 | 166 | 247 | 8 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.40e-06 | 167 | 247 | 8 | d1a13d6ada572d8ddb2da95e6e122d2b705fad7f | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.96e-06 | 174 | 247 | 8 | 3c47d069bd836599a8d40eae485c23d4d3487517 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-06 | 178 | 247 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.64e-06 | 180 | 247 | 8 | d33bb00f2b7d07dda9015cb8eafd742c2b2e9ace | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.70e-06 | 186 | 247 | 8 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.70e-06 | 186 | 247 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.18e-05 | 191 | 247 | 8 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-3|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.18e-05 | 191 | 247 | 8 | 80d30d8eedb4c70b58440646325bc04c5700803e | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.22e-05 | 192 | 247 | 8 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.27e-05 | 193 | 247 | 8 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.32e-05 | 194 | 247 | 8 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | facs-Heart-RA-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 195 | 247 | 8 | f4fdcc0b851392086e9618e76ee6a0b540d5fb3c | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 195 | 247 | 8 | cad21edd90bf3e2fefdf5773a59cb1a664a69ddd | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 195 | 247 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.47e-05 | 197 | 247 | 8 | 0c8650bde08e1317baee4793201645d86f16e15d | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.47e-05 | 197 | 247 | 8 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial|World / Primary Cells by Cluster | 1.58e-05 | 199 | 247 | 8 | b9763ac9857a60db6f1f104fe1e9ea2266cf931b | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial-Endothelial-24|World / Primary Cells by Cluster | 1.58e-05 | 199 | 247 | 8 | 0b4edf3e359749827ef978a77b5267ddde732d71 | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial-Endothelial|World / Primary Cells by Cluster | 1.58e-05 | 199 | 247 | 8 | 9e01eee126247a0696c71b019f855a8a41a0ede3 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.64e-05 | 200 | 247 | 8 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 200 | 247 | 8 | ced14d83222dbebca85c40540e76824e683354f3 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.00e-05 | 149 | 247 | 7 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.18e-05 | 151 | 247 | 7 | bbf735c6433c3fc2feedb24ed6f48c51d545fb60 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-05 | 151 | 247 | 7 | f41c6558a5874b6464c157027fdf202257c60e5b | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Brinp3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.55e-05 | 163 | 247 | 7 | b0aa4a620bd58011225b42ea6dda04e3101ba342 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-mucus_secreting_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-05 | 165 | 247 | 7 | 7e7643834ed483aec04f513cca38d6367fda9ff8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.84e-05 | 165 | 247 | 7 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.84e-05 | 165 | 247 | 7 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.84e-05 | 165 | 247 | 7 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.15e-05 | 167 | 247 | 7 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 4.31e-05 | 168 | 247 | 7 | 8697b40b2ec2cce68ef3beb4792eb3eff29be053 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.31e-05 | 168 | 247 | 7 | b08458164d270d625b8ee390122d1c2ce8c653db | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.31e-05 | 168 | 247 | 7 | b8c65542a0701ae31f49d332d87a64578e24b4e3 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.31e-05 | 168 | 247 | 7 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.31e-05 | 168 | 247 | 7 | 8c95093b1ea45826f62893edd3c410fe53b563a4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.31e-05 | 168 | 247 | 7 | 217770a94ace446cdfc7687b459dece707576e76 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.47e-05 | 169 | 247 | 7 | 0425d2580ed325178f522c0093ff4623de6ce7a8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.47e-05 | 169 | 247 | 7 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.47e-05 | 169 | 247 | 7 | fec669968a77060bd77ee8695034e35a642c984f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.64e-05 | 170 | 247 | 7 | 84d49a1f2989d98bd0acf9ec2d59f1042fc0f55b | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.82e-05 | 171 | 247 | 7 | 1ae4b6a25bc9c1065cf5d95998ebcc70aee21ab5 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.82e-05 | 171 | 247 | 7 | 3d26ef58fe5231373d7df9ac79d225546918cf82 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Serpinf1-Serpinf1_Clrn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.08e-05 | 118 | 247 | 6 | 702548d8187d54e8814375e5ae7609631fc71d5f | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.38e-05 | 174 | 247 | 7 | 16204ff504b7b382b4d90ca35003ad5336020e07 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.38e-05 | 174 | 247 | 7 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.58e-05 | 175 | 247 | 7 | 90302e8a44858ef3b2a165b88284d4788d591a99 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|metastatic_Brain / Location, Cell class and cell subclass | 5.58e-05 | 175 | 247 | 7 | b732c6a423c28856211002107d8c611dcfb6f265 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-05 | 176 | 247 | 7 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.78e-05 | 176 | 247 | 7 | 77516048aefbe1f48e825052756df0c310c1c486 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-05 | 176 | 247 | 7 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.78e-05 | 176 | 247 | 7 | 96779273b94345250cf53ba671203345b43d9e00 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-05 | 176 | 247 | 7 | 64e426f5e84884ce2c29acf6f4b958962a63927f | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.99e-05 | 177 | 247 | 7 | 4672cc75225a4a23b298afa8ce439628262519db | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.21e-05 | 178 | 247 | 7 | 9fc5688cf705a74398d24e10e0aab4758612e72b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.41e-05 | 123 | 247 | 6 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.43e-05 | 179 | 247 | 7 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.66e-05 | 180 | 247 | 7 | 66c7b02d85e32ba3e7530d0c4aff17e7525ccdd8 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-05 | 181 | 247 | 7 | fb64da1dde37fe6ba7de2586cd58848ac1974f24 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.89e-05 | 181 | 247 | 7 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-05 | 181 | 247 | 7 | cd81bc307e2bc42c1e9b24d5645ab65fa18c6133 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-05 | 182 | 247 | 7 | dc55de945c6f78f32eb3a1b3520835eb8417e068 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.14e-05 | 182 | 247 | 7 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-05 | 182 | 247 | 7 | 010a7364da46101cb5068891fd7bc712ea8f13bd | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-05 | 182 | 247 | 7 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-05 | 182 | 247 | 7 | b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.64e-05 | 184 | 247 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.64e-05 | 184 | 247 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 7.64e-05 | 184 | 247 | 7 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.64e-05 | 184 | 247 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-05 | 185 | 247 | 7 | 38486b69c48dc5e1c4e1488208fa8954a973eccb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-05 | 185 | 247 | 7 | 3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658 | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.46e-05 | 187 | 247 | 7 | 908df5520142d65fe32a003d26be14965082a1ea | |
| ToppCell | 10x5'-Lung-Mast|Lung / Manually curated celltypes from each tissue | 8.46e-05 | 187 | 247 | 7 | f8ac5ca5cbe9c6f3d8c0fffc20fe08ca1aea43c0 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 8.46e-05 | 187 | 247 | 7 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.46e-05 | 187 | 247 | 7 | 406ff9327d3109fe1e251629c4c617b00a573dc2 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 8.46e-05 | 187 | 247 | 7 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.46e-05 | 187 | 247 | 7 | c1dfab0b0d7f519b9f13f4e0365ab41c4b2ae1ec | |
| ToppCell | 10x5'-Lung-Mast-Mast_cells|Lung / Manually curated celltypes from each tissue | 8.46e-05 | 187 | 247 | 7 | da275d2c774b3e6a8ed77f777dd0676ecf2ddd2c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.46e-05 | 187 | 247 | 7 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.46e-05 | 187 | 247 | 7 | b486cc5ac678051fea9d4c7db53b26a5a8427e60 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.46e-05 | 187 | 247 | 7 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | Control-Classical_Monocyte-|Classical_Monocyte / Disease condition and Cell class | 8.71e-05 | 130 | 247 | 6 | 4433b40b099845f113993b6ecf85ec594b4b9219 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.74e-05 | 188 | 247 | 7 | 0e2d1b21f0a7ee306e7dae16fc8c19d16a467883 | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.04e-05 | 189 | 247 | 7 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.34e-05 | 190 | 247 | 7 | ed100e271aac82806f59e0c613ccda63f59100c1 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.34e-05 | 190 | 247 | 7 | 7df63e5e0dd395676f4fc18cad0d8b2428390943 | |
| Drug | Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; HL60; HT_HG-U133A | ZNF609 ZNF862 SEPTIN9 ZNF236 ZKSCAN5 NRP1 NFATC1 GFOD2 PLXNA1 RANBP3 NBEA ALPK1 ARHGAP35 | 2.00e-07 | 195 | 244 | 13 | 2173_DN |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | CDK8 NRP1 PIK3C3 NFE2L2 RBM47 DSCAM SCAF8 NSD1 FRYL SETD2 ATF7IP TPX2 | 7.09e-07 | 183 | 244 | 12 | 7498_DN |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Up 200; 9.4uM; MCF7; HT_HG-U133A | INHBA KATNB1 INTS1 SRCAP ASTN2 SEMA4A PLXNA1 DSCAM TCOF1 RANBP3 ADGRG2 ARHGEF1 | 1.63e-06 | 198 | 244 | 12 | 6263_UP |
| Drug | (cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; PC3; HT_HG-U133A | PRSS8 ZNF862 KLF3 MTMR3 ASTN2 CPLANE1 HDAC5 ADGRG2 SMARCA2 ZNF839 SRRM2 GGA1 | 1.72e-06 | 199 | 244 | 12 | 4543_DN |
| Drug | geldanamycin | BDP1 SETX ATRX INHBA DIP2A PRRC2C SLAIN2 FN1 RTTN FRYL HEATR1 USP10 SETD2 SMARCA2 SRRM2 MAP2K2 | 2.82e-06 | 371 | 244 | 16 | ctd:C001277 |
| Drug | Y-27632; Up 200; 3uM; MCF7; HT_HG-U133A_EA | ZNF609 PPRC1 ASTN2 SEMA4A HDAC5 RANBP3 ELP1 ALPK1 NCOR2 RAB11FIP5 AHNAK2 | 8.00e-06 | 193 | 244 | 11 | 948_UP |
| Drug | Lithocholic acid [434-13-9]; Up 200; 10.6uM; MCF7; HT_HG-U133A | GP6 ZNF609 RYR1 NFATC1 XYLB PCBP3 NCOR2 ZFP64 PAX4 NUP188 PLCE1 | 8.40e-06 | 194 | 244 | 11 | 4373_UP |
| Drug | Midecamycin [35457-80-8]; Up 200; 5uM; MCF7; HT_HG-U133A | ZNF609 KATNB1 ETS2 SPTBN5 FN1 RANBP3 SPTLC1 ACSF2 ARHGAP35 NUP188 ZMYM6 | 9.26e-06 | 196 | 244 | 11 | 5345_UP |
| Drug | (1)-Nipecotic acid [498-95-3]; Down 200; 31uM; PC3; HT_HG-U133A | INHBA ZKSCAN5 NRP1 DIP2A SCML2 DNMBP RBM47 VEZT RANBP3 PRPF38B ZCCHC4 | 1.02e-05 | 198 | 244 | 11 | 7296_DN |
| Drug | Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; HL60; HT_HG-U133A | KATNB1 INTS1 DIP2A SCAPER FN1 RANBP3 NSD1 CHD8 ALPK1 VWA5A ARHGEF1 | 1.02e-05 | 198 | 244 | 11 | 1299_DN |
| Drug | Pirlindole mesylate [60762-57-4]; Down 200; 12.4uM; HL60; HT_HG-U133A | JADE3 INHBA SEPTIN9 ZNF280B GFOD2 XYLB ALDH3A2 TCOF1 ARHGAP35 ZNF839 GGA1 | 1.07e-05 | 199 | 244 | 11 | 3140_DN |
| Drug | Methotrexate [59-05-2]; Up 200; 8.8uM; PC3; HG-U133A | PRSS8 ZNF609 SETX ETS2 ZKSCAN5 NFATC1 RBM47 RANBP3 FSD1 PTPRU PLCE1 | 1.07e-05 | 199 | 244 | 11 | 1957_UP |
| Drug | Pentetic acid [67-43-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A | ATG2A SRCAP ZKSCAN5 XYLB ALK RANBP3 TOM1 ALPK1 ARHGAP35 SLC5A3 ZMYM6 | 1.12e-05 | 200 | 244 | 11 | 5264_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.98e-05 | 183 | 244 | 10 | 3510_DN | |
| Drug | Rimexolone [49697-38-3]; Down 200; 10.8uM; HL60; HT_HG-U133A | HIVEP1 KATNB1 NRP1 DNMBP RBM47 FN1 RANBP3 BHLHE40 ZCCHC4 CFAP44 | 3.12e-05 | 184 | 244 | 10 | 2955_DN |
| Drug | carbamazepine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | ZNF609 ZNF318 SCAPER NOS1 HDAC5 ALPK1 ARHGAP35 SRRM2 GGA1 HERPUD1 | 4.10e-05 | 190 | 244 | 10 | 952_UP |
| Drug | 0175029-0000 [211245-78-2]; Up 200; 10uM; PC3; HT_HG-U133A | SEPTIN9 NACA MED14 PDS5A FN1 FSD1 BHLHE40 CELSR2 MYO15A GGA1 | 4.48e-05 | 192 | 244 | 10 | 6875_UP |
| Drug | semustine; Up 200; 100uM; PC3; HT_HG-U133A | SRCAP GFOD2 PDS5A ASTN2 XYLB PTPRU PAPOLG ZCCHC4 GGA1 HERPUD1 | 4.68e-05 | 193 | 244 | 10 | 7545_UP |
| Drug | Beta-sistosterol [83-46-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | ZNF609 SEPTIN9 KLF3 SRCAP ZKSCAN5 PIK3R2 ARHGAP35 ZCCHC4 VWA5A ATP6V0A4 | 4.68e-05 | 193 | 244 | 10 | 4154_DN |
| Drug | Etofylline [519-37-9]; Up 200; 17.8uM; PC3; HT_HG-U133A | DGKA CEACAM1 SCAPER ASTN2 FN1 DSCAM E2F2 ALPK1 SETD2 SMARCA2 | 4.68e-05 | 193 | 244 | 10 | 2093_UP |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; HL60; HT_HG-U133A | SEPTIN9 ZKSCAN5 NRP1 NFATC1 PIK3R2 FN1 ALPK1 ARHGAP35 SETD2 PCIF1 | 4.89e-05 | 194 | 244 | 10 | 6199_DN |
| Drug | Azapropazone [13539-59-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A | INHBA ETS2 KLF3 ASTN2 PLAGL1 SPTLC1 ADGRG2 VWA5A RAB11FIP5 CFAP44 | 5.10e-05 | 195 | 244 | 10 | 6522_DN |
| Drug | Lisinopril [83915-83-7]; Up 200; 9uM; MCF7; HT_HG-U133A | ZNF609 SCAPER PLAGL1 NOS1 RANBP3 FSD1 PTPRU PAPOLG RAB11FIP5 GGA1 | 5.10e-05 | 195 | 244 | 10 | 7403_UP |
| Drug | Phenazopyridine hydrochloride [136-40-3]; Up 200; 16uM; MCF7; HT_HG-U133A | 5.10e-05 | 195 | 244 | 10 | 6234_UP | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 5.10e-05 | 195 | 244 | 10 | 5241_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | ZNF609 ZKSCAN5 PTPRF SCAPER MERTK HDAC5 RANBP3 ARHGAP35 CELSR2 ZNF839 | 5.10e-05 | 195 | 244 | 10 | 5591_DN |
| Drug | Furazolidone [67-45-8]; Down 200; 17.8uM; MCF7; HT_HG-U133A | ZNF609 KATNB1 SRCAP PRKD3 PLAGL1 ALK RANBP3 ZCCHC4 VWA5A SRRM2 | 5.10e-05 | 195 | 244 | 10 | 3358_DN |
| Drug | Chrysene-1,4-quinone [100900-16-1]; Down 200; 15.4uM; PC3; HT_HG-U133A | 5.33e-05 | 196 | 244 | 10 | 7139_DN | |
| Drug | Brinzolamide [138890-62-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A | RASSF2 ZNF862 KATNB1 SRCAP PIK3R2 MERTK HDAC5 RANBP3 ALPK1 IGSF1 | 5.33e-05 | 196 | 244 | 10 | 5016_DN |
| Drug | Hydrochlorothiazide [58-93-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A | ZNF862 ZNF236 SCAPER HDAC5 ALPK1 ACSF2 PRX CELSR2 SMARCA2 AHNAK2 | 5.33e-05 | 196 | 244 | 10 | 1487_UP |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | ZNF609 ZNF318 SRCAP PRKD3 PIK3R2 PLXNA1 TNS3 ARHGAP35 PCIF1 SMARCA2 | 5.33e-05 | 196 | 244 | 10 | 1696_DN |
| Drug | Hydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A | DLG5 INHBA NFATC1 ACTR8 FN1 VEZT ZFP64 ATP6V0A4 MYO15A AHNAK2 | 5.56e-05 | 197 | 244 | 10 | 2889_UP |
| Drug | Tubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; MCF7; HT_HG-U133A | ZNF609 ZNF862 KLF3 SEC24D SCAPER DSCAM ELP1 PTPRU RAB11FIP5 GGA1 | 5.56e-05 | 197 | 244 | 10 | 5449_DN |
| Drug | Sotalol hydrochloride [959-24-0]; Down 200; 13uM; MCF7; HT_HG-U133A | 5.56e-05 | 197 | 244 | 10 | 4160_DN | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A_EA | DLG5 ZNF609 SEPTIN9 MED14 SRCAP MTMR3 PLAGL1 MERTK ALPK1 ARHGAP35 | 5.56e-05 | 197 | 244 | 10 | 1013_UP |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Up 200; 3uM; MCF7; HT_HG-U133A | SRCAP ZKSCAN5 KCNJ4 XYLB OLFML2B RANBP3 NCOR2 ARHGEF1 ZFP64 PLCE1 | 5.56e-05 | 197 | 244 | 10 | 6840_UP |
| Drug | Vinpocetine [42971-09-5]; Down 200; 11.4uM; MCF7; HT_HG-U133A | ZNF609 MED14 ZKSCAN5 SCAPER SEMA4A RANBP3 SPTLC1 ADGRG2 ARHGEF1 SMARCA2 | 5.56e-05 | 197 | 244 | 10 | 3174_DN |
| Drug | LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A | ZNF609 ATRX KLF3 SRCAP ZKSCAN5 SCAPER MTMR3 PLXNA1 PAPOLG AHNAK2 | 5.56e-05 | 197 | 244 | 10 | 1641_UP |
| Drug | Dextromethorphan hydrobromide monohydrate [6700-34-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A | KLF3 ZNF318 ACTR8 RANBP3 ACSF2 SLC5A3 ORC1 PCIF1 IGSF1 SRRM2 | 5.56e-05 | 197 | 244 | 10 | 2636_DN |
| Drug | Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; PC3; HT_HG-U133A | ZNF862 INTS1 SRCAP ZKSCAN5 SCML2 PDS5A EP400 RANBP3 CFAP44 AKAP1 | 5.80e-05 | 198 | 244 | 10 | 6353_DN |
| Drug | Ketorolac tromethamine [74103-07-4]; Up 200; 10.6uM; HL60; HT_HG-U133A | SEPTIN9 MED14 KLF3 RYR1 NRP1 KCNJ4 MERTK NRCAM ARHGAP35 PLCE1 | 5.80e-05 | 198 | 244 | 10 | 3110_UP |
| Drug | Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; MCF7; HT_HG-U133A | INHBA SEPTIN9 ZKSCAN5 PTPRF PLXNA1 ACTR8 FN1 ALPK1 ADGRG2 SMARCA2 | 5.80e-05 | 198 | 244 | 10 | 6790_DN |
| Drug | Biperiden hydrochloride [1235-82-1]; Up 200; 11.4uM; HL60; HT_HG-U133A | NRP1 SEC24D ALDH3A2 DNMBP DSCAM SPTLC1 ADGRG2 NUP188 MYO15A MYBPC3 | 5.80e-05 | 198 | 244 | 10 | 2460_UP |
| Drug | Novobiocin sodium salt [1476-53-5]; Up 200; 6.4uM; MCF7; HT_HG-U133A | GP6 RYR1 SEC24D NOS1 SLC5A3 ADGRG2 ZFP64 CSPG4 NUP188 MYO15A | 5.80e-05 | 198 | 244 | 10 | 4392_UP |
| Drug | Guanethidine sulfate [60-02-6]; Down 200; 13.4uM; PC3; HT_HG-U133A | ZNF862 SRCAP MERTK ACTR8 HDAC5 FN1 SPTLC1 ARHGAP35 ZCCHC4 SMARCA2 | 5.80e-05 | 198 | 244 | 10 | 5731_DN |
| Drug | Dehydroisoandosterone 3-acetate [853-23-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | ZNF609 INTS1 MED14 PTPRF PTPRU ARHGAP35 ZCCHC4 RAB11FIP5 IGSF1 ZNF839 | 5.80e-05 | 198 | 244 | 10 | 5019_DN |
| Drug | Chenodiol [474-25-9]; Up 200; 10.2uM; MCF7; HT_HG-U133A | ZNF609 KATNB1 MED14 SCAPER PLAGL1 MERTK OLFML2B RANBP3 SETD2 SMARCA2 | 5.80e-05 | 198 | 244 | 10 | 7433_UP |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Down 200; 8uM; HL60; HG-U133A | SEPTIN9 DIP2A SEMA4A NOS1 PLXNA1 TCOF1 ALPK1 ORC1 SMARCA2 ZNF839 | 5.80e-05 | 198 | 244 | 10 | 1553_DN |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | ZNF609 KATNB1 ZNF318 PTPRF SCAPER ASTN2 FN1 TOM1 ARHGAP35 SRRM2 | 6.05e-05 | 199 | 244 | 10 | 7439_UP |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; MCF7; HT_HG-U133A | DLG5 KATNB1 MED14 ZNF318 SEC24D PIK3R2 ACTR8 FN1 RANBP3 ELP1 | 6.05e-05 | 199 | 244 | 10 | 5695_DN |
| Drug | Dropropizine (R,S) [17692-31-8]; Up 200; 17uM; MCF7; HT_HG-U133A | ZNF609 ATRX PSG5 DGKA SPTBN5 SCAPER RANBP3 RAB11FIP5 NUP188 GGA1 | 6.05e-05 | 199 | 244 | 10 | 7429_UP |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | ZNF609 SEPTIN9 KLF3 GFOD2 PIK3R2 SCAPER PLXNA1 VEZT ALPK1 ACSF2 | 6.05e-05 | 199 | 244 | 10 | 2744_DN |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | INTS1 SRCAP GFOD2 ASTN2 NRCAM RANBP3 FSD1 PTPRU SETD2 SMARCA2 | 6.31e-05 | 200 | 244 | 10 | 3405_DN |
| Drug | chrysene | HLA-DOA DGKA RYR1 FAT2 HMCN2 NFATC1 PTPRZ1 CPT1C GCN1 NRCAM TCOF1 NSD1 PRPF38B HEATR1 BHLHE40 SLC5A3 CELSR2 HMCN1 SH3D19 ATP6V0A4 SRRM2 CDH13 EXOC4 | 6.85e-05 | 871 | 244 | 23 | ctd:C031180 |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 8.29e-05 | 167 | 244 | 9 | 5217_DN | |
| Drug | G 3012 | 9.12e-05 | 132 | 244 | 8 | CID000120739 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.18e-04 | 175 | 244 | 9 | 3787_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.18e-04 | 175 | 244 | 9 | 7387_DN | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.29e-04 | 177 | 244 | 9 | 4652_DN | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 1.41e-04 | 179 | 244 | 9 | 1005_UP | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.59e-04 | 182 | 244 | 9 | 3630_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.59e-04 | 182 | 244 | 9 | 5802_DN | |
| Drug | Thiostrepton [1393-48-2]; Up 200; 2.4uM; HL60; HT_HG-U133A | 1.73e-04 | 184 | 244 | 9 | 2462_UP | |
| Drug | 2-deoxy-D-glucose; Up 200; 10000uM; MCF7; HG-U133A | 1.88e-04 | 186 | 244 | 9 | 344_UP | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 1.88e-04 | 186 | 244 | 9 | 6996_UP | |
| Drug | Lansoprazole [103577-45-3]; Down 200; 10.8uM; HL60; HT_HG-U133A | 2.11e-04 | 189 | 244 | 9 | 2967_DN | |
| Drug | Thioguanosine [85-31-4]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 2.20e-04 | 190 | 244 | 9 | 2619_UP | |
| Drug | Ald1.1-H_000455; Up 200; 10uM; PC3; HT_HG-U133A | 2.29e-04 | 191 | 244 | 9 | 7547_UP | |
| Drug | Thiostrepton [1393-48-2]; Down 200; 2.4uM; PC3; HT_HG-U133A | 2.29e-04 | 191 | 244 | 9 | 4563_DN | |
| Drug | Desipramine hydrochloride [58-28-6]; Up 200; 13.2uM; PC3; HT_HG-U133A | ZNF609 DGKA RYR1 SEC24D PRDM10 SCAPER ARHGAP35 CSPG4 HERPUD1 | 2.29e-04 | 191 | 244 | 9 | 6693_UP |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.38e-04 | 192 | 244 | 9 | 5567_UP | |
| Drug | clozapine; Down 200; 10uM; HL60; HT_HG-U133A | ZNF609 SRCAP ZKSCAN5 SCAPER RANBP3 VWA5A CSPG4 NUP188 MYO15A | 2.38e-04 | 192 | 244 | 9 | 6188_DN |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; SKMEL5; HG-U133A | 2.38e-04 | 192 | 244 | 9 | 629_UP | |
| Drug | Cinoxacin [28657-80-9]; Down 200; 15.2uM; HL60; HT_HG-U133A | 2.38e-04 | 192 | 244 | 9 | 2722_DN | |
| Drug | Enilconazole [35554-44-0]; Down 200; 13.4uM; HL60; HT_HG-U133A | 2.47e-04 | 193 | 244 | 9 | 3139_DN | |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; PC3; HT_HG-U133A | 2.47e-04 | 193 | 244 | 9 | 2114_DN | |
| Drug | Cefalonium [5575-21-3]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 2.47e-04 | 193 | 244 | 9 | 7341_UP | |
| Drug | Clozapine [5786-21-0]; Up 200; 12.2uM; PC3; HT_HG-U133A | 2.47e-04 | 193 | 244 | 9 | 4670_UP | |
| Drug | Bicuculline | 2.48e-04 | 29 | 244 | 4 | ctd:D001640 | |
| Drug | alpha-Santonin [481-06-1]; Up 200; 16.2uM; PC3; HT_HG-U133A | 2.57e-04 | 194 | 244 | 9 | 4531_UP | |
| Drug | Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; HL60; HG-U133A | MED14 ASCC2 PLAGL1 PLXNA1 FN1 RANBP3 PCIF1 SMARCA2 RAB11FIP5 | 2.57e-04 | 194 | 244 | 9 | 1437_DN |
| Drug | Albendazole [54965-21-8]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.57e-04 | 194 | 244 | 9 | 7164_UP | |
| Drug | Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A | ZNF609 ATG2A SEC24D SCAPER ASTN2 SEMA4A RANBP3 RAB11FIP5 GGA1 | 2.57e-04 | 194 | 244 | 9 | 7354_DN |
| Drug | Fillalbin [4540-25-4]; Up 200; 13.8uM; PC3; HT_HG-U133A | 2.57e-04 | 194 | 244 | 9 | 4092_UP | |
| Drug | Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.57e-04 | 194 | 244 | 9 | 3454_DN | |
| Drug | Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; PC3; HG-U133A | 2.57e-04 | 194 | 244 | 9 | 1949_UP | |
| Drug | AC1L3VO5 | 2.58e-04 | 116 | 244 | 7 | CID000123015 | |
| Drug | Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A | SEPTIN9 SCAPER NOS1 RANBP3 TOM1 PTPRU ARHGAP35 ADGRG2 ATP6V0A4 | 2.67e-04 | 195 | 244 | 9 | 2317_DN |
| Drug | Spiramycin [8025-81-8]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 2.67e-04 | 195 | 244 | 9 | 3844_UP | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.67e-04 | 195 | 244 | 9 | 1522_DN | |
| Drug | Homosalate [118-56-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 2.67e-04 | 195 | 244 | 9 | 4355_UP | |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 2.67e-04 | 195 | 244 | 9 | 5330_UP | |
| Drug | genistein; Down 200; 1uM; MCF7; HG-U133A | 2.67e-04 | 195 | 244 | 9 | 268_DN | |
| Drug | Phenacetin [62-44-2]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 2.67e-04 | 195 | 244 | 9 | 4111_UP | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | ZNF862 SRCAP ZKSCAN5 RANBP3 PTPRU ARHGAP35 BHLHE40 ARHGEF1 ATP6V0A4 | 2.67e-04 | 195 | 244 | 9 | 3923_DN |
| Drug | Tenoxicam [59804-37-4]; Up 200; 11.8uM; HL60; HT_HG-U133A | 2.67e-04 | 195 | 244 | 9 | 2501_UP | |
| Drug | Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.67e-04 | 195 | 244 | 9 | 4784_DN | |
| Drug | Cyanocobalamin [68-19-9]; Up 200; 3uM; MCF7; HT_HG-U133A | 2.77e-04 | 196 | 244 | 9 | 3252_UP | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 2.77e-04 | 196 | 244 | 9 | 1684_UP | |
| Drug | Merbromin [129-16-8]; Up 200; 5uM; MCF7; HT_HG-U133A | CEACAM1 KCNJ4 PLXNA1 VEZT VWA5A ARHGEF1 ZFP64 ATP6V0A4 MYBPC3 | 2.77e-04 | 196 | 244 | 9 | 4722_UP |
| Disease | developmental and epileptic encephalopathy 87 (implicated_via_orthology) | 6.53e-05 | 2 | 239 | 2 | DOID:0112221 (implicated_via_orthology) | |
| Disease | acute kidney failure (biomarker_via_orthology) | 1.37e-04 | 61 | 239 | 5 | DOID:3021 (biomarker_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 1.68e-04 | 100 | 239 | 6 | C0010606 | |
| Disease | Dysautonomia, Familial | 1.95e-04 | 3 | 239 | 2 | C0013364 | |
| Disease | serum urea measurement | 2.02e-04 | 195 | 239 | 8 | EFO_0009795 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.50e-04 | 152 | 239 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | coronary thrombosis, GM11992 | 2.72e-04 | 16 | 239 | 3 | EFO_0001124, EFO_1000883 | |
| Disease | cholesterol in very small VLDL measurement | 3.05e-04 | 40 | 239 | 4 | EFO_0022231 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 3.28e-04 | 17 | 239 | 3 | EFO_0022232 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 3.28e-04 | 17 | 239 | 3 | DOID:0060307 (is_implicated_in) | |
| Disease | occupational asthma (is_implicated_in) | 3.88e-04 | 4 | 239 | 2 | DOID:0080820 (is_implicated_in) | |
| Disease | Sotos' syndrome | 3.88e-04 | 4 | 239 | 2 | C0175695 | |
| Disease | free cholesterol in very small VLDL measurement | 5.70e-04 | 47 | 239 | 4 | EFO_0022275 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 6.27e-04 | 21 | 239 | 3 | EFO_0022246 | |
| Disease | phospholipids in medium LDL measurement | 6.68e-04 | 49 | 239 | 4 | EFO_0022183 | |
| Disease | cholesterol in medium LDL measurement | 6.68e-04 | 49 | 239 | 4 | EFO_0022224 | |
| Disease | cholesterol in small LDL measurement | 6.68e-04 | 49 | 239 | 4 | EFO_0022227 | |
| Disease | testosterone measurement | UBR1 DCHS2 INHBA NHSL2 SEPTIN9 GLYCTK WDR81 ZNF318 SRCAP ZKSCAN5 PTPRF NFATC1 NFE2L2 FAM186A PLAGL1 DNMBP TNS3 DSCAM NCOR2 HMCN1 SMARCA2 MYO15A | 7.40e-04 | 1275 | 239 | 22 | EFO_0004908 |
| Disease | total lipids in medium LDL | 8.38e-04 | 52 | 239 | 4 | EFO_0022180 | |
| Disease | cholesterol in small VLDL measurement | 9.00e-04 | 53 | 239 | 4 | EFO_0022228 | |
| Disease | Treacher Collins syndrome (implicated_via_orthology) | 9.59e-04 | 6 | 239 | 2 | DOID:2908 (implicated_via_orthology) | |
| Disease | extraversion measurement | 9.59e-04 | 6 | 239 | 2 | EFO_0007913 | |
| Disease | pulse pressure measurement | INHBA ZNF318 SRCAP STEAP2 FAM186B PRKD3 DIP2A NFE2L2 ASCC2 PIF1 TNS3 SLAIN2 PCBP3 FN1 DSCAM RBM33 NBEA FRYL DOT1L MAP2K2 CDH13 PLCE1 MYBPC3 | 1.00e-03 | 1392 | 239 | 23 | EFO_0005763 |
| Disease | cataract | 1.05e-03 | 141 | 239 | 6 | MONDO_0005129 | |
| Disease | migraine disorder, diastolic blood pressure | 1.06e-03 | 25 | 239 | 3 | EFO_0006336, MONDO_0005277 | |
| Disease | cholesterol to total lipids in large LDL percentage | 1.11e-03 | 56 | 239 | 4 | EFO_0022235 | |
| Disease | aspartate aminotransferase measurement | BDP1 DLG5 BORCS5 HMCN2 ASTN2 MERTK DNMBP GCN1 CNTN2 WNK2 NSD1 ARHGAP35 NCOR2 MYO15A HERPUD1 PLCE1 MYBPC3 | 1.20e-03 | 904 | 239 | 17 | EFO_0004736 |
| Disease | phospholipids in LDL measurement | 1.26e-03 | 58 | 239 | 4 | EFO_0022294 | |
| Disease | creatinine measurement | RYR1 NFATC1 NFE2L2 PRRC2C MTMR3 ASTN2 XYLB MYBPHL ALDH3A2 RBM47 DSCAM SCAF8 NSD1 USP10 CELSR2 CSPG4 DIP2C CDH13 | 1.33e-03 | 995 | 239 | 18 | EFO_0004518 |
| Disease | Morphine Abuse | 1.34e-03 | 7 | 239 | 2 | C0600272 | |
| Disease | Morphine Dependence | 1.34e-03 | 7 | 239 | 2 | C0026552 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.34e-03 | 148 | 239 | 6 | C0279702 | |
| Disease | serum gamma-glutamyl transferase measurement | UBR1 DLG5 ATRX SEPTIN9 ASTN2 DNMBP GCN1 SEC16B E2F2 ARHGAP35 NCOR2 SETD2 CELSR2 PTCD1 PCIF1 EXOC4 PLCE1 | 1.35e-03 | 914 | 239 | 17 | EFO_0004532 |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 1.35e-03 | 59 | 239 | 4 | EFO_0022248 | |
| Disease | Autistic Disorder | 1.37e-03 | 261 | 239 | 8 | C0004352 | |
| Disease | neutrophil percentage of leukocytes | HIVEP1 SEPTIN9 PPIL6 KLF3 PRKD3 PRR14 KCNE4 BORCS5 NFATC1 PLAGL1 MERTK SETD2 PTCD1 | 1.52e-03 | 610 | 239 | 13 | EFO_0007990 |
| Disease | Non-Small Cell Lung Carcinoma | 1.76e-03 | 156 | 239 | 6 | C0007131 | |
| Disease | microcephaly (is_implicated_in) | 1.77e-03 | 8 | 239 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | SALL3 RASSF2 NFATC1 PZP SHANK1 CAD FN1 NRCAM TCOF1 PTPRU ARHGEF1 TPX2 DIP2C EXOC4 | 1.88e-03 | 702 | 239 | 14 | C0009402 |
| Disease | cholesterol in large VLDL measurement | 1.93e-03 | 65 | 239 | 4 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 1.93e-03 | 65 | 239 | 4 | EFO_0022230 | |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 1.99e-03 | 31 | 239 | 3 | DOID:3328 (biomarker_via_orthology) | |
| Disease | cholesterol to total lipids in very large HDL percentage | 1.99e-03 | 31 | 239 | 3 | EFO_0022243 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 1.99e-03 | 31 | 239 | 3 | EFO_0022249 | |
| Disease | total lipids in small VLDL | 2.16e-03 | 67 | 239 | 4 | EFO_0022148 | |
| Disease | total lipids in large VLDL | 2.16e-03 | 67 | 239 | 4 | EFO_0022175 | |
| Disease | free cholesterol in large VLDL measurement | 2.28e-03 | 68 | 239 | 4 | EFO_0022265 | |
| Disease | androsterone sulfate measurement | 2.39e-03 | 33 | 239 | 3 | EFO_0021117 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.61e-03 | 34 | 239 | 3 | EFO_0008317, EFO_0008596, EFO_0020944 | |
| Disease | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 2.61e-03 | 34 | 239 | 3 | EFO_0008317, EFO_0008596, EFO_0020947 | |
| Disease | migraine disorder | 2.67e-03 | 357 | 239 | 9 | MONDO_0005277 | |
| Disease | Anemia, Sickle Cell | 2.82e-03 | 10 | 239 | 2 | C0002895 | |
| Disease | cholesteryl esters to total lipids in very large HDL percentage | 3.08e-03 | 36 | 239 | 3 | EFO_0022257 | |
| Disease | asthma, endometriosis | 3.10e-03 | 74 | 239 | 4 | EFO_0001065, MONDO_0004979 | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 3.33e-03 | 37 | 239 | 3 | EFO_0022281 | |
| Disease | peanut allergy measurement, parental genotype effect measurement | 3.42e-03 | 11 | 239 | 2 | EFO_0005939, EFO_0007017 | |
| Disease | Intellectual Disability | 3.71e-03 | 447 | 239 | 10 | C3714756 | |
| Disease | triglycerides to total lipids in large VLDL percentage | 3.87e-03 | 39 | 239 | 3 | EFO_0022332 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 3.95e-03 | 128 | 239 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 3.95e-03 | 128 | 239 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 3.95e-03 | 128 | 239 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 3.95e-03 | 128 | 239 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 3.95e-03 | 128 | 239 | 5 | C0007134 | |
| Disease | pulmonary function measurement, forced expiratory volume, smoking behaviour measurement | 4.09e-03 | 12 | 239 | 2 | EFO_0003892, EFO_0004314, EFO_0005671 | |
| Disease | Gastrointestinal Diseases | 4.09e-03 | 12 | 239 | 2 | C0017178 | |
| Disease | Behavior Disorders | 4.09e-03 | 12 | 239 | 2 | C0004930 | |
| Disease | Mental disorders | 4.09e-03 | 12 | 239 | 2 | C0004936 | |
| Disease | Functional Gastrointestinal Disorders | 4.09e-03 | 12 | 239 | 2 | C0559031 | |
| Disease | Cholera Infantum | 4.09e-03 | 12 | 239 | 2 | C1565321 | |
| Disease | Charcot-Marie-Tooth Disease | 4.09e-03 | 12 | 239 | 2 | C0007959 | |
| Disease | Mental Disorders, Severe | 4.09e-03 | 12 | 239 | 2 | C4046029 | |
| Disease | Diagnosis, Psychiatric | 4.09e-03 | 12 | 239 | 2 | C0376338 | |
| Disease | myeloid white cell count | DLG5 KLF3 ZKSCAN5 HAVCR1 DIP2A TNS3 FN1 E2F2 PRX SETD2 SH3D19 SSH2 DOT1L MAP2K2 GGA1 PLCE1 | 4.27e-03 | 937 | 239 | 16 | EFO_0007988 |
| Disease | Congenital small ears | 4.46e-03 | 41 | 239 | 3 | C0152423 | |
| Disease | Nodular glomerulosclerosis | 4.46e-03 | 41 | 239 | 3 | C0017667 | |
| Disease | triglycerides in large LDL measurement | 5.10e-03 | 43 | 239 | 3 | EFO_0022319 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 5.10e-03 | 43 | 239 | 3 | EFO_0022290 | |
| Disease | orofacial cleft, sex interaction measurement | 5.31e-03 | 86 | 239 | 4 | EFO_0008343, MONDO_0000358 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 5.41e-03 | 398 | 239 | 9 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | concentration of large LDL particles measurement | 5.44e-03 | 44 | 239 | 3 | EFO_0022160 | |
| Disease | Diabetic Nephropathy | 5.44e-03 | 44 | 239 | 3 | C0011881 | |
| Disease | cholesterol in medium VLDL measurement | 5.44e-03 | 44 | 239 | 3 | EFO_0022225 | |
| Disease | glioblastoma (is_marker_for) | 5.44e-03 | 44 | 239 | 3 | DOID:3068 (is_marker_for) | |
| Disease | triacylglycerol 48:4 measurement | 5.58e-03 | 14 | 239 | 2 | EFO_0010407 | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 5.58e-03 | 14 | 239 | 2 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | total lipids in very small VLDL measurement | 5.80e-03 | 45 | 239 | 3 | EFO_0022156 | |
| Disease | Bipolar Disorder | HLA-E DTNBP1 PIK3C3 ASTN2 HDAC5 DSCAM TOM1 GRIA1 BHLHE40 SLC5A3 | 5.80e-03 | 477 | 239 | 10 | C0005586 |
| Disease | mean reticulocyte volume | FOXK2 PPRC1 ZNF318 HAVCR1 DIP2A PTPRF CAD EP400 RTTN E2F2 ATF7IP TPX2 PCIF1 MAP2K2 | 5.89e-03 | 799 | 239 | 14 | EFO_0010701 |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 6.16e-03 | 46 | 239 | 3 | EFO_0008317, EFO_0008596, EFO_0020943 | |
| Disease | BMI-adjusted adiponectin measurement | 6.40e-03 | 15 | 239 | 2 | EFO_0007737 | |
| Disease | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage | 6.40e-03 | 15 | 239 | 2 | EFO_0022328 | |
| Disease | response to olanzapine | 6.40e-03 | 15 | 239 | 2 | GO_0097333 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 6.40e-03 | 15 | 239 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | free cholesterol in small VLDL measurement | 6.54e-03 | 47 | 239 | 3 | EFO_0022272 | |
| Disease | free cholesterol in medium VLDL measurement | 6.54e-03 | 47 | 239 | 3 | EFO_0022269 | |
| Disease | cognitive function measurement | HIVEP1 FAM186B PTPRF PRRC2C KCNJ4 CRYBG1 PDS5A WNK2 SEC16B PCBP3 DSCAM NBEA BHLHE40 ATF7IP FAM222A RAB11FIP5 CDH13 EXOC4 PPP1R16A MYBPC2 MYBPC3 | 6.65e-03 | 1434 | 239 | 21 | EFO_0008354 |
| Disease | Malignant neoplasm of breast | ETS2 MED14 ZNF318 FAM83F MTMR3 ASTN2 HERC2 ALK FN1 NRCAM SPTLC1 ELP1 EPG5 SETD2 ZFP64 DIP2C GGA1 | 6.85e-03 | 1074 | 239 | 17 | C0006142 |
| Disease | lung small cell carcinoma (is_marker_for) | 7.27e-03 | 16 | 239 | 2 | DOID:5409 (is_marker_for) | |
| Disease | X-21410 measurement | 7.27e-03 | 16 | 239 | 2 | EFO_0800813 | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 7.35e-03 | 49 | 239 | 3 | EFO_0021897 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPETKVTIQVSLEPL | 496 | Q86YH2 | |
| ISKIVPPTSLDVPLI | 281 | P30926 | |
| SPLSIKIFPTNIRVP | 56 | Q5U5X8 | |
| VALAKPPVVSVPAAV | 2911 | Q96L91 | |
| KPPVPVISSAVLLSQ | 1516 | Q9HCE0 | |
| NPLLPAPILVKSVNT | 2311 | A6H8Y1 | |
| VQLRADPAIKEPLPV | 46 | Q92667 | |
| KTAVLRVPVPPNVAF | 106 | Q92888 | |
| TPLVSRSVPPVKLED | 2051 | Q9HCK8 | |
| NSPLKPLADLDPVVV | 181 | Q9BWU1 | |
| PATLKVVAIRPAIQI | 651 | Q6UVK1 | |
| RKVEPGQAIPLTAVP | 2276 | Q6UVK1 | |
| QKNETVISPFILPPV | 556 | Q96M83 | |
| VISPFILPPVLTESK | 561 | Q96M83 | |
| KVLQPTVFPVVPRLL | 356 | P33121 | |
| VKRPIVPALVPESLQ | 26 | Q9H981 | |
| VDSSVLLQALKPIPP | 391 | O14503 | |
| PFTIPQVLRTKVPRE | 641 | Q9H1I8 | |
| IPVVPRATVLSQVPK | 261 | Q8IZP9 | |
| EIFGPILPIVPVKNV | 331 | P51648 | |
| LVDQNLKPAPPLVVR | 626 | Q6XZF7 | |
| PAPPELIRAIINKIN | 386 | Q96CM8 | |
| RVPKRPIINTPVVSI | 2271 | Q9HCU4 | |
| PPQLVTPTSVKAIIL | 6 | Q8IYM0 | |
| LSTVQPNKLPVSIPL | 871 | Q8TEK3 | |
| PNKLPVSIPLASVVL | 876 | Q8TEK3 | |
| SPVPRQKRSIVVSPI | 131 | P55290 | |
| ATLDPLLLQPQVPKV | 96 | Q5HYR2 | |
| PPVAERAILPALKQT | 341 | Q96LY2 | |
| AISPLNSPVRPVAKV | 856 | Q9UKL3 | |
| LILPPIQSPREKEIQ | 1836 | Q96MT7 | |
| SAPQLPKVDLLTVPA | 301 | Q6NXP0 | |
| RQLPPTVVKPLILAT | 1891 | Q2TAZ0 | |
| VLRQIPPAVVKPLIV | 2031 | Q96BY7 | |
| PPAVVKPLIVATEAT | 2036 | Q96BY7 | |
| PVSKSFVVPPVELSI | 596 | O75129 | |
| KLQPATPIAPQVVIR | 136 | Q96QP1 | |
| VLPLSQPVGPVNKSV | 371 | Q6IQ32 | |
| VVVPRVRVSKAPAPT | 421 | A6NCL7 | |
| RPDVTQPVPKAALLN | 71 | P08476 | |
| KPVLPALTINPTIAE | 6 | P36507 | |
| VLRPAVLQAPQPKAL | 171 | Q9H6Z4 | |
| FKGTVVTPVQVPLLP | 391 | Q96EV2 | |
| VTIALLEIPLPVTNP | 1111 | P20742 | |
| VPNLEIPTVNPVAIK | 426 | A0AV96 | |
| QRLPPPEKVLSAVVQ | 2416 | Q96L73 | |
| PVRIISVTPVKNIDP | 1201 | Q29RF7 | |
| PLTVPKVQISEVDAP | 101 | P50749 | |
| ARLPEGKPVQVATPI | 426 | Q9BXF6 | |
| IIFLKCPVPPTQELL | 641 | Q8IXQ6 | |
| APAVVSVTPAVKDPL | 231 | Q96CB8 | |
| EPEPVTLLVKSPNQR | 6 | Q15011 | |
| RELQESKITVLPAPP | 351 | P48050 | |
| QTPLILSVKPSFLVP | 1026 | Q9HCM3 | |
| LQPEVPPSKQLLSTI | 391 | Q9H8H0 | |
| IQPVPVDPQIKLIST | 311 | Q6NSI4 | |
| NLRDPPTNIIIIPEK | 331 | Q6NSI4 | |
| IIDLSQVPHLPVLVP | 1731 | Q9Y618 | |
| LRIPQAALAKPISIP | 726 | Q86TB9 | |
| KPASQPTIPIVGIIA | 296 | P13747 | |
| SVIVQPGKRPLPVES | 236 | P57682 | |
| KPLPVVSGLRSVQVP | 136 | Q8WWG9 | |
| DPSVPLKIPLQRNVI | 116 | Q9BQP7 | |
| RAISPSIKEPSVVPI | 101 | Q8N201 | |
| PKLLEDLVQPPTITQ | 36 | Q92823 | |
| VQINIKAIPSPPTEV | 276 | Q12866 | |
| LSLQVEGKPPTPVVA | 371 | Q8NE63 | |
| RLPIKPVAAPVLAQD | 2531 | Q9UKN7 | |
| VVTPAAVLAPPKAEA | 501 | Q01167 | |
| RKQSPVPALPIVVQL | 2451 | O95714 | |
| LQALKFLPVPSAPVI | 156 | Q9BTV5 | |
| AKAQIVVTDPPPQLV | 506 | Q8NDA2 | |
| LTVQASPVVKPLPSV | 3936 | Q8NDA2 | |
| SPVVKPLPSVVRAVA | 3941 | Q8NDA2 | |
| KTPEQPQIVLIPSTV | 1541 | Q5HYC2 | |
| PQIVLIPSTVGTPIK | 1546 | Q5HYC2 | |
| VVASTPAPKAEPAII | 441 | Q9BVA0 | |
| SNRPLEPPSEFIIKV | 126 | Q86UP0 | |
| QALPSSLVPLEKPVT | 31 | Q9HCN6 | |
| VVKPITLAARNLPQP | 721 | Q9UIW2 | |
| VEPALRKPPAIASVV | 246 | Q9NYQ8 | |
| PKRITEVFPAVIPQN | 486 | Q8N119 | |
| VKPISNSPPVLDVFL | 261 | Q8NHC6 | |
| LLPPVLNPIIDSVKT | 291 | A6NGY5 | |
| IPFPVEKIINLPVVD | 466 | Q16236 | |
| RAKLAAIIPDPVVAP | 551 | Q12996 | |
| PVVAPSIVPVLKDEV | 561 | Q12996 | |
| PVEQGKPVIPAAVLA | 341 | P15036 | |
| ITLQVPNPSELRAKP | 281 | Q96EV8 | |
| LVEVLKQIPVHPVPD | 131 | O94915 | |
| LAPIPVTVKREPEEL | 906 | O95644 | |
| ILETIDKANLPVLPP | 441 | P23743 | |
| PKLAPVVIPAQFLEE | 1121 | Q8TDM6 | |
| QKSVLPTAIPAVLPA | 11 | O94806 | |
| LIKPAPPTQQDSRII | 16 | P20774 | |
| TVPLPILLARKVPSV | 86 | Q7L4E1 | |
| TVPLESIKPSNILPV | 501 | Q9UJY5 | |
| SVPVLDAELFIPPKI | 1306 | O95163 | |
| VPKLTTPPVNTRVLA | 2081 | Q92616 | |
| LITNETPKPETIIIP | 251 | Q8N5I3 | |
| EEVPELTLPIIKPNR | 756 | Q9NQV6 | |
| KTVLPAVPSDPILVE | 1196 | P23471 | |
| AVPIPADLPPQKLVI | 631 | Q9Y5F7 | |
| SPSLPERPLQVKVVG | 16 | Q8IXY8 | |
| SKPPVTLRLVVPASQ | 126 | P57721 | |
| LQSPPIITLEPVETV | 4436 | Q96RW7 | |
| IETALPALVVPILEP | 431 | O60244 | |
| RVTQPLGPPTKAVDL | 121 | P29475 | |
| NFAELIVKEPPTPIA | 276 | Q92729 | |
| KPRLATPPVVARIAQ | 76 | O43316 | |
| ITAVAQPGIKAVPPR | 3281 | Q6V1P9 | |
| NPTDVVVAVFPKPLI | 386 | O14786 | |
| PDVAPPLLVKLVEAI | 121 | O00459 | |
| GLVRVIPLAPKDVVP | 131 | Q13415 | |
| ETQKFDILVPIVPPQ | 231 | Q6GPH6 | |
| AAVIVEKPLSVPPAQ | 566 | Q9BWT3 | |
| LPRQPVPSVQDTVRK | 171 | Q8TCG5 | |
| SVPLIDVTNLPTPRK | 226 | Q96A65 | |
| LPKGTVIVQPEPVLN | 121 | P46100 | |
| DILPKPVISASPTIR | 681 | Q8N6C5 | |
| VPPPVSAALQGIKSI | 1801 | Q9P2D3 | |
| PKPIRLVQDLPEELV | 31 | Q9H4Z3 | |
| VIAVKAPPQTRLEVP | 266 | Q14209 | |
| SRAINVPPRVTVLPK | 106 | P06340 | |
| VPPRVTVLPKSRVEL | 111 | P06340 | |
| PIPPVTLEEKQTLTR | 186 | Q8IVS8 | |
| TVPSTPIQPIAEERK | 2381 | Q9H799 | |
| IIVTELSPVVAKPQI | 316 | P13688 | |
| IVNKVVTPLSPPTNL | 1166 | P02751 | |
| RVINELSFKPPVTEP | 441 | Q2WGN9 | |
| ISIPPPLTRQISVKA | 71 | Q3B7J2 | |
| PDVIKLQEIPTFQPL | 51 | Q969J3 | |
| AEVVPVPIEVPLTRK | 406 | Q9Y2E4 | |
| ILIPCQPRAAPKAVV | 436 | Q02246 | |
| LKPVVSTEAPPIIFA | 26 | O14548 | |
| SIKTLELNVLVPPAP | 141 | Q96AP7 | |
| ISLQPLPVILHVPVA | 776 | Q6VMQ6 | |
| LVIERPGPPQSIKLV | 141 | A2RUH7 | |
| IPPVIQPEIISKNLV | 316 | Q9ULL0 | |
| HVKPAIQEPPIVISD | 111 | Q96QF7 | |
| PDPFVPVLNTAVKLI | 1686 | Q9H583 | |
| VIPPASEKTLPIQAQ | 621 | Q9Y4K1 | |
| AELVPVPIEVPLTRK | 421 | Q14689 | |
| LSQPIPLIIEEKQIP | 2241 | A6NE01 | |
| SKVVNIPVRIPVSRP | 286 | Q96LA5 | |
| HSIPVTVEVKPVLPR | 26 | Q9UQL6 | |
| EPPKLLPQIDIVNIS | 51 | P42261 | |
| NSPLKPLADLDPVVV | 181 | P49336 | |
| VNSKTDLVPPLPVTR | 616 | Q9HCS5 | |
| RAPAEQVPRSPVIKI | 241 | Q6NUJ5 | |
| LQIPVAPAVPTVSLV | 641 | Q9UPN6 | |
| VPATNVNTVLRIPPK | 971 | Q9BY12 | |
| KPVLPTVPTSVGLQL | 516 | Q9BXA9 | |
| DPRPVETLNVIIPEK | 2736 | P21817 | |
| PIPIRVETAQPAVEK | 651 | Q9H329 | |
| NDLTPVDPVLVKSRP | 676 | Q5VV67 | |
| PDTVPQPSLRIIAEK | 86 | Q92613 | |
| DLPSVPVFDRTLPVK | 516 | Q5VVW2 | |
| KVPVPSQQLFEPSRV | 1156 | Q13615 | |
| IIEKLDQQIPPRPFT | 76 | Q8N323 | |
| PPRKVEVEPLNSTAV | 711 | P10586 | |
| LEQIKLPGNPPVTLI | 51 | O95868 | |
| VQVPPDQPRLTVSKT | 1376 | O60469 | |
| EVPPRPVVNQTVKCL | 156 | Q86VV8 | |
| VPDTTLVKRPVEPQA | 166 | Q9H611 | |
| KVEPVALAPSPVIPR | 746 | Q5VWG9 | |
| ILIKPEQETDPLPVV | 76 | Q8IUI4 | |
| LPKELPADAVNLTIP | 361 | Q9UM63 | |
| PPQEPVKTLRSLVNI | 76 | Q96PX1 | |
| SSLPVQPEVALKRVP | 2566 | Q9UQ35 | |
| SSTPVRPPIVKQLIL | 216 | Q9P270 | |
| SRISPIQKPQGLDPV | 326 | P51531 | |
| GKDIPLPVTVQRTPL | 201 | Q9H6Q3 | |
| PVPVLQSKPLVDIDL | 191 | Q5HYK7 | |
| PAAVTSAQVIKPPLI | 946 | Q13428 | |
| PPLVPKEAATLLVAR | 431 | Q5HYW2 | |
| PEQPRTVIKAPRVST | 2146 | Q9P212 | |
| PVTPDFSLLPKIILQ | 346 | Q96RN1 | |
| PVVLSTPAQLIAPVV | 2151 | Q8NFP9 | |
| SLEIVPPKVTTTPIV | 121 | Q96D42 | |
| SDVELIPLPLEPQVK | 586 | Q8NEB9 | |
| IPLPLEPQVKIRGII | 591 | Q8NEB9 | |
| PSQKVDRAPQPTLVV | 141 | Q9BWN1 | |
| RPQIIKEVLAVPNSI | 561 | Q9H3S1 | |
| PLEPVSTVQVEPAVK | 1106 | Q9Y520 | |
| PLLKLTAPAVEAPVE | 506 | Q96I34 | |
| KTPEPAPRRTEITIV | 141 | Q9UHD8 | |
| DLVPIKPLPNVVTLQ | 76 | Q8IY81 | |
| IQSILKVPQPVPLIA | 1631 | Q7Z333 | |
| TVIVSLLTPPPTKEQ | 526 | P53794 | |
| AQLLPQPLVSIPTEK | 271 | Q96M53 | |
| PIEIVNKTLPIVAIT | 251 | Q8NFT2 | |
| VAPSVSLLTPKPLQQ | 176 | Q16651 | |
| VLEIKPPPSAVTQRN | 376 | Q6ZRS2 | |
| QKALSITLVQEPPPV | 1331 | Q68CZ2 | |
| PLALPEVVKSQRPLQ | 266 | Q68BL8 | |
| LTTVVTPEKPIPIFI | 1251 | Q9NRY4 | |
| KDLVTVEQVLPPVEP | 376 | Q8NEG4 | |
| IPLAAVIKPFATIPS | 331 | O94855 | |
| TTEPVPIQLKAPLTL | 426 | Q9NRP7 | |
| EKCLPPPSIRVVVTV | 436 | O15269 | |
| RAKVPVPLIGPENIV | 126 | Q9NRC6 | |
| APSEKNSIPIPTIII | 1146 | Q9Y566 | |
| DPSPLQVAVKTLPEV | 1141 | Q9UM73 | |
| LNLPLEAPPISKVRV | 5451 | Q8IVF2 | |
| VPLAGALVLPPVKSQ | 536 | Q9H2X0 | |
| RLKLPSIPLVPVSAQ | 141 | Q15785 | |
| RVVVKSEPLSSPEPQ | 326 | O15062 | |
| QPLKESAVLTPRVPT | 196 | P17040 | |
| AAVLPQVRPKTLIPD | 66 | Q96EK2 | |
| QVRPKTLIPDSLPVA | 71 | Q96EK2 | |
| SETQAVPLPLPKRVE | 996 | Q76I76 | |
| ETLKQLIQPICIPPT | 706 | Q7RTY8 | |
| DPPVVPTASKLVVIT | 51 | A6NJB7 | |
| VLQPPGTSVPIVKNI | 236 | Q9UQR0 | |
| ESVLVRTILPKNNPP | 96 | O60784 | |
| VNVKVPPVPLAAPRL | 441 | P35590 | |
| TQPEPTQPKASVLLL | 31 | Q8N7X2 | |
| PEVRLPEVQLPKVSE | 676 | Q9BXM0 | |
| TLFPRIPVPVQKNID | 216 | Q5VTL8 | |
| EVVKLAPNPRLAATP | 491 | O75191 | |
| TPAVLPIHLLVPVVN | 256 | O15014 | |
| KSLCNTVIPIIPLQP | 1201 | Q8IWV7 | |
| RLKPPSNVVSPLEQA | 826 | Q5SRE5 | |
| VTFPLQPKPDVNLTI | 531 | O00534 | |
| EEITPPSISAPQKIV | 401 | P08922 | |
| PSAEIIVLKEPPTIR | 1036 | Q96RU2 | |
| KEPVTPVAAKIIPAT | 306 | Q63HK5 | |
| LDPNARPLVPEVSIK | 151 | P27708 | |
| PVPLPVDVAVRSLKE | 226 | Q9BYW2 | |
| IPPSVETPAQIVEKF | 431 | Q96JE7 | |
| PTEVAAPPLEKILSV | 676 | A8K0R7 | |
| QKPPILPSREAAEVL | 1131 | O60290 | |
| IVVQLLEKSPLTPLP | 76 | Q9HBG4 | |
| ISEVKPVLPELAFPS | 976 | Q641Q2 | |
| PSVLLPSVPAVAIKV | 76 | O95789 | |
| LILVGDPKQLPPTIQ | 1831 | Q86YA3 | |
| SPVRIFTNIPPNKII | 356 | Q9H5U6 | |
| PPAISPLVSEKQVEV | 366 | Q14694 | |
| VRVGKTNIPVPDIPL | 606 | Q9UL36 | |
| QEKPPVQLTPALVRS | 886 | Q9Y4F4 | |
| LPPVPKEAVSGRVQL | 1641 | Q9Y3S1 | |
| PQITNPKAEITRFVP | 566 | Q9Y2W2 | |
| AVLKSLSPVDPVEPI | 611 | Q9HBM0 | |
| PLTSVPELVPVKVAN | 171 | O43915 | |
| PLDKSIVIRPLEPQP | 911 | Q15029 | |
| PPPLFSKVVIVLIDA | 61 | Q5H8A4 | |
| KDQVLPQTSVLPGRP | 6 | Q53SZ7 | |
| LTAVALKPPPVELEV | 426 | O75127 | |
| PITAQVTIEALPPKV | 31 | Q15238 | |
| VKAPVSRSPPREQVI | 2236 | Q5VUA4 | |
| PKAPVITLPSEAREQ | 276 | Q9NTW7 | |
| LPPELRPLGSQVQKV | 1616 | P15822 | |
| EPPLIPKLLVQTIQE | 601 | Q562E7 | |
| PKEVPVSLQPVLDTL | 811 | Q562E7 | |
| LPVLQVPSLPLKDSQ | 186 | Q9Y2L8 | |
| VPFKPQIPEARTVEI | 521 | Q9ULW0 | |
| QPPAVKTVEVPIHQL | 186 | Q6ZT21 | |
| QVVKVTDTTLVPEPP | 46 | Q8NCA9 | |
| LPRVPKVQSNGPVSI | 171 | A6NMK8 | |
| IPHAVLPPTVDVVAL | 296 | Q9P206 | |
| LATLVLAPEIPKSVP | 721 | E9PAV3 | |
| LKEVLVAPAPESTPI | 1681 | E9PAV3 | |
| VKEPPVLIVTPLEDQ | 341 | Q14324 | |
| AQPVTIREIAEPPKI | 826 | Q14324 | |
| ATLVLQVVDKPSPPQ | 1056 | Q14896 |